UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
Form 10-Q
 
þ
 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2018
OR
 
¨
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                      to                    

Commission file number: 0-12015
 

  HEALTHCARE SERVICES GROUP, INC.
(Exact name of registrant as specified in its charter)
Pennsylvania
 
23-2018365
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S Employer Identification No.)
 
 
3220 Tillman Drive, Suite 300, Bensalem, PA
 
19020
(Address of principal executive offices)
 
(Zip Code)
Registrant’s telephone number, including area code:
(215) 639-4274

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES   þ     NO   ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES   þ     NO   ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer 
þ
 
Accelerated filer 
o
 
 
 
 
 
 
 
 
 
Non-accelerated filer  
o
(Do not check if a smaller reporting company)
 
 
 
 
 
 
 
 
 
 
 
 
 
Smaller reporting company  
o
 
 
 
 
 
 
 
 
 
 
 
 
Emerging growth company
o
 
 
 
 
 
 
 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act .
o
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). YES   ¨     NO   þ

Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date. Common Stock, $.01 par value: 73,740,000 shares outstanding as of July 25, 2018 .



Healthcare Services Group, Inc.
Quarterly Report on Form 10-Q
For the Period Ended June 30, 2018

TABLE OF CONTENTS

 
 
 
 
 
 
 
 
 
 
 
 
 



2



Table of Contents

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This report and documents incorporated by reference into it may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are not historical facts but rather are based on current expectations, estimates and projections about our business and industry, and our beliefs and assumptions. Words such as “believes,” “anticipates,” “plans,” “expects,” “will,” “goal,” and similar expressions are intended to identify forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by us that any of our plans will be achieved. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Such forward-looking information is also subject to various risks and uncertainties. Such risks and uncertainties include, but are not limited to, risks arising from our providing services exclusively to the healthcare industry, primarily providers of long-term care; having a significant portion of our consolidated revenues contributed by one customer during the six months ended June 30, 2018 ; credit and collection risks associated with the healthcare industry; our claims experience related to workers’ compensation and general liability insurance; the effects of changes in, or interpretations of laws and regulations governing the healthcare industry, our workforce and services provided, including state and local regulations pertaining to the taxability of our services and other labor-related matters such as minimum wage increases; continued realization of tax benefits arising from our corporate reorganization and self-funded health insurance program; risks associated with the reorganization of our corporate structure; realization of our expectations regarding the impact of the Tax Cuts and Jobs Act on our financial results; and the risk factors described in Part I of our Form 10-K for the fiscal year ended December 31, 2017 under “Government Regulation of Clients,” “Competition” and “Service Agreements and Collections,” and under Item IA. “Risk Factors” in such Form 10-K.

These factors, in addition to delays in payments from clients and/or clients in bankruptcy or clients with which we are in litigation to collect payment, have resulted in, and could continue to result in, significant additional bad debts in the near future. Additionally, our operating results would be adversely affected if unexpected increases in the costs of labor and labor-related costs, materials, supplies and equipment used in performing services (including the impact of potential tariffs) could not be passed on to our clients.

In addition, we believe that to improve our financial performance we must continue to obtain service agreements with new clients, retain and provide new services to existing clients, achieve modest price increases on current service agreements with existing clients and maintain internal cost reduction strategies at our various operational levels. Furthermore, we believe that our ability to sustain the internal development of managerial personnel is an important factor impacting future operating results and the successful execution of our projected growth strategies.

3



Table of Contents

PART I — FINANCIAL INFORMATION
Item 1. Financial Statements (Unaudited)
Healthcare Services Group, Inc.
Consolidated Balance Sheets
(in thousands, except per share amounts)
(Unaudited)

 
June 30,
2018
 
December 31,
2017
ASSETS:
 
 
 
Current assets:
 
 
 
Cash and cash equivalents
$
13,155

 
$
9,557

Marketable securities, at fair value
74,928

 
73,221

Accounts and notes receivable, less allowance for doubtful accounts  of $49,709 an d $11,985 as of June 30, 2018 and December 31, 2017, respectively
343,665

 
378,720

Inventories and supplies
41,424

 
42,393

Prepaid expenses and other assets
27,625

 
23,515

Total current assets
500,797

 
527,406

Property and equipment, net
13,254

 
13,509

Goodwill
51,084

 
51,084

Other intangible assets, less accumulated amortization of $15,084 and $12,853 as of June 30, 2018 and December 31, 2017, resp ectively
28,650

 
30,881

Notes receivable — long-term portion
37,386

 
15,476

Deferred compensation funding, at fair value
30,697

 
28,885

Deferred income taxes
7,753

 
7,498

Other noncurrent assets
1,257

 
1,264

Total assets
$
670,878

 
$
676,003




 


LIABILITIES AND STOCKHOLDERS’ EQUITY:


 


Current liabilities:
 
 
 
Accounts payable
$
69,269

 
$
74,463

Accrued payroll, accrued and withheld payroll taxes
27,423

 
32,139

Other accrued expenses
3,495

 
4,561

Borrowings under line of credit
40,505

 
35,382

Income taxes payable

 
15,378

Accrued insurance claims
23,702

 
22,245

Total current liabilities
164,394

 
184,168

Accrued insurance claims — long-term portion
67,459

 
62,454

Deferred compensation liability
30,891

 
29,429

Commitments and contingencies


 


STOCKHOLDERS’ EQUITY:
 
 
 
Common stock, $.01 par value; 100,000 shares authorized; 75,200 and 74,960 shares issued, and 73,733 and 73,436 shares outstanding as of June 30, 2018 and December 31, 2017, respectively
752

 
750

Additional paid-in capital
255,894

 
244,363

Retained earnings
161,269

 
163,860

Accumulated other comprehensive (loss) income, net of taxes
(204
)
 
837

Common stock in treasury, at cost, 1,467 and 1,524 shares as of June 30, 2018 and December 31, 2017, respectively
(9,577
)
 
(9,858
)
Total stockholders’ equity
408,134

 
399,952

Total liabilities and stockholders’ equity
$
670,878

 
$
676,003


See accompanying notes.

4



Table of Contents

Healthcare Services Group, Inc.
Consolidated Statements of Comprehensive Income
(in thousands, except per share amounts)
(Unaudited)

 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2018
 
2017
 
2018
 
2017
Revenues
$
503,732

 
$
470,876

 
$
1,005,542

 
$
875,366

Operating costs and expenses:
 
 
 
 
 
 
 
Costs of services provided
437,618

 
407,322

 
907,522

 
752,892

Selling, general and administrative expense
34,118

 
31,991

 
67,895

 
60,201

Other income, net:
 
 
 
 
 
 
 
Investment and interest, net
1,320

 
1,515

 
1,796

 
3,084

Income before income taxes
33,316

 
33,078

 
31,921

 
65,357

Income tax provision
7,502

 
10,527

 
6,035

 
20,789

Net income
$
25,814

 
$
22,551

 
$
25,886

 
$
44,568

 
 
 
 
 
 
 
 
Per share data:
 
 
 
 
 
 
 
Basic earnings per common share
$
0.35

 
$
0.31

 
$
0.35

 
$
0.61

Diluted earnings per common share
$
0.35

 
$
0.30

 
$
0.35

 
$
0.60

 
 
 
 
 
 
 
 
Weighted average number of common shares outstanding:
 
 
 
 
 
 
 
Basic
73,982

 
73,276

 
73,947

 
73,176

Diluted
74,487

 
74,269

 
74,606

 
74,108

 
 
 
 
 
 
 
 
Comprehensive income:
 
 
 
 
 
 
 
Net income
$
25,814

 
$
22,551

 
$
25,886

 
$
44,568

Other comprehensive income:
 
 
 
 
 
 
 
Unrealized gain (loss) on available-for-sale marketable securities, net of taxes
97

 
602

 
(1,041
)
 
1,081

Total comprehensive income
$
25,911

 
$
23,153

 
$
24,845

 
$
45,649


See accompanying notes.


5



Table of Contents

Healthcare Services Group, Inc.
Consolidated Statements of Cash Flows
(in thousands)
(Unaudited)
 
Six Months Ended June 30,
 
2018
 
2017
Cash flows from operating activities:
 
 
 
Net income
$
25,886

 
$
44,568

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
Depreciation and amortization
4,836

 
4,239

Bad debt provision
39,387

 
2,100

Stock-based compensation expense, net of tax benefit from equity compensation plans
2,026

 
315

Amortization of premium on marketable securities
653

 
569

Unrealized gain on deferred compensation fund investments
(1,259
)
 
(2,304
)
Changes in operating assets and liabilities:
 
 
 
Accounts and notes receivable
(26,242
)
 
(69,187
)
Inventories and supplies
969

 
(238
)
Prepaid expenses and other assets
(2,458
)
 
(6,089
)
Deferred compensation funding
(531
)
 
98

Accounts payable and other accrued expenses
(6,628
)
 
5,550

Accrued payroll, accrued and withheld payroll taxes
(1,690
)
 
1,572

Income taxes payable
(15,955
)
 
7,343

Accrued insurance claims
6,461

 
2,399

Deferred compensation liability
1,940

 
2,504

Net cash provided by (used in) operating activities
27,395

 
(6,561
)
Cash flows from investing activities:
 
 
 
Disposals of fixed assets
222

 
169

Additions to property and equipment
(2,572
)
 
(2,674
)
Purchases of marketable securities
(9,453
)
 
(15,939
)
Sales of marketable securities
5,775

 
14,681

Cash paid for acquisitions

 
(2,584
)
Net cash used in investing activities
(6,028
)
 
(6,347
)
Cash flows from financing activities:
 
 
 
Dividends paid
(28,398
)
 
(27,374
)
Reissuance of treasury stock pursuant to Dividend Reinvestment Plan
46

 
48

Proceeds from the exercise of stock options
5,460

 
7,257

Net proceeds from short-term borrowings
5,123

 
16,182

Net cash used in financing activities
(17,769
)
 
(3,887
)
Net change in cash and cash equivalents
3,598

 
(16,795
)
Cash and cash equivalents at beginning of the period
9,557

 
23,853

Cash and cash equivalents at end of the period
$
13,155

 
$
7,058



See accompanying notes.

6



Table of Contents

Healthcare Services Group, Inc.
Consolidated Statement of Stockholders’ Equity
(in thousands)
(Unaudited)

 
For the six months ended June 30, 2018
 
Common Stock
 
Additional Paid-in Capital
 
Retained Earnings
 
Accumulated Other Comprehensive Income (Loss), net of taxes
 
Treasury Stock
 
Stockholders’ Equity
 
Shares
 
Amount
 
 
 
 
 
Balance — December 31, 2017
74,960

 
$
750

 
$
244,363

 
$
163,860

 
$
837

 
$
(9,858
)
 
$
399,952

Comprehensive income:

 

 

 

 

 

 

Net income for the period

 

 

 
25,886

 

 

 
25,886

Unrealized loss on available-for-sale marketable securities, net of taxes

 

 

 

 
(1,041
)
 

 
(1,041
)
Comprehensive income for the period

 

 

 

 

 

 
24,845

Exercise of stock options and other stock-based compensation, net of shares tendered for payment
236

 
2

 
5,458

 

 

 

 
5,460

Share-based compensation expense — stock options, restricted stock

 

 
2,806

 

 

 

 
2,806

Treasury shares issued for Deferred Compensation Plan funding and redemptions

 

 
549

 

 

 
(72
)
 
477

Shares issued pursuant to Employee Stock Plan

 

 
2,474

 

 

 
346

 
2,820

Dividends paid and accrued

 

 

 
(28,477
)
 

 

 
(28,477
)
Shares issued pursuant to Dividend Reinvestment Plan

 

 
39

 

 

 
7

 
46

Other
4

 

 
205

 

 

 

 
205

Balance — June 30, 2018
75,200

 
$
752

 
$
255,894

 
$
161,269

 
$
(204
)
 
$
(9,577
)
 
$
408,134


See accompanying notes.

7



Table of Contents

Healthcare Services Group, Inc.
Notes to Consolidated Financial Statements
(Unaudited)

Note 1— Description of Business and Significant Accounting Policies

Nature of Operations

Healthcare Services Group, Inc. (the “Company”) provides management, administrative and operating expertise and services to the housekeeping, laundry, linen, facility maintenance and dietary service departments of the healthcare industry, including nursing homes, retirement complexes, rehabilitation centers and hospitals located throughout the United States. Although the Company does not directly participate in any government reimbursement programs, the Company’s clients receive government reimbursements related to Medicare and Medicaid. Therefore, they are directly affected by any legislation relating to Medicare and Medicaid reimbursement programs.

The Company provides services primarily pursuant to full service agreements with its clients. In such agreements, the Company is responsible for the day-to-day management of employees located at the clients’ facilities. The Company also provides services on the basis of management-only agreements for a limited number of clients. The agreements with clients typically provide for renewable one year service terms, cancelable by either party upon 30 to 90  days’ notice after an initial period of 60 to 120 days.

The Company is organized into two reportable segments: housekeeping, laundry, linen and other services (“Housekeeping”), and dietary department services (“Dietary”).

Housekeeping consists of managing the clients’ housekeeping departments, which are principally responsible for the cleaning, disinfecting and sanitizing of resident rooms and common areas of a client’s facility, as well as the laundering and processing of the bed linens, uniforms, resident personal clothing and other assorted linen items utilized at a client facility.

Dietary consists of managing the clients’ dietary departments, which are principally responsible for food purchasing, meal preparation and dietitian professional services, which includes the development of menus that meet residents’ dietary needs.

Unaudited Interim Financial Data

The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) for interim financial information and the requirements of Form 10-Q and Article 10 of Regulation S-X. Accordingly, these consolidated financial statements do not include all of the information and footnotes necessary for a complete presentation of financial position, results of operations and cash flows. However, in the Company’s opinion, all adjustments which are of a normal recurring nature and are necessary for a fair presentation have been reflected in these consolidated financial statements. The balance sheet shown in this report as of December 31, 2017 has been derived from, and does not include, all of the disclosures contained in the financial statements for the year ended December 31, 2017 . These financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017 . The results of operations for the six months ended June 30, 2018 are not necessarily indicative of the results that may be expected for any future period.

Use of Estimates in Financial Statements

In preparing financial statements in conformity with U.S. GAAP, estimates and assumptions are made that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities, and the reported amounts of revenues and expenses. Actual results could differ from those estimates. Significant estimates are used in determining, but are not limited to, the Company’s allowance for doubtful accounts, accrued insurance claims, valuations, deferred taxes and reviews for potential impairment. The estimates are based upon various factors including current and historical trends, as well as other pertinent industry and regulatory authority information. Management regularly evaluates this information to determine if it is necessary to update the basis for its estimates and to adjust for known changes.

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of Healthcare Services Group, Inc. and its wholly-owned subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation.


8




Cash and Cash Equivalents

Cash and cash equivalents are held in U.S. financial institutions or in custodial accounts with U.S. financial institutions. Cash equivalents are defined as short-term, highly liquid investments with a maturity of three months or less at time of purchase that are readily convertible into cash and have insignificant interest rate risk.

Accounts and Notes Receivable

Accounts and notes receivable consist of Housekeeping and Dietary segment receivables from contracts with customers. Accounts receivables initially are recorded at the transaction amount, and recorded after the Company has an unconditional right to payment where only the passage of time is required before payment is received. Each reporting period, the Company evaluates the collectability of outstanding receivable balances and records an allowance for doubtful accounts representing an estimate of probable losses. Additions to the allowance for doubtful accounts are made by recording a charge to bad debt expense reported in costs of services provided.

Notes receivable are initially recorded as an alternative to accounts receivable to enhance the collectability of amounts due, by providing a definitive repayment plan and providing a means by which to further evidence the amounts owed.

Refer to Note 3— Accounts and Notes Receivable herein for further information.

Inventories and Supplies

Inventories and supplies include housekeeping, linen and laundry supplies, as well as food provisions and supplies. Non-linen inventories and supplies are stated at cost to approximate a first-in, first-out (FIFO) basis. Linen supplies are amortized on a straight-line basis over their estimated useful life of 24 months.

Revenue Recognition

The Company recognizes revenue from service agreements with customers when or as the promised goods and services are provided to customers. Revenues are reported net of sales taxes that are collected from customers and remitted to taxing authorities.

The guidance under the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification subtopic 606 Revenue from Contracts with Customers (“ASC 606”) became effective and was adopted by the Company as of January 1, 2018, by applying the modified retrospective method for contracts that were not completed as of January 1, 2018. The standard requires the Company to recognize revenue as the promised goods and services within the terms of the Company’s contracts are performed and satisfied. The amount of revenue which the Company recognizes is based on the consideration which the Company expects to be entitled to in exchange for contracted promised goods and services. The adoption of this standard did not have a material impact to the Company's accounting for revenue earned relating to the Housekeeping and Dietary segments. The Company also did not recognize an opening adjustment to retained earnings as a result of the adoption of the standard. See Note 2—Revenue herein for additional revenue disclosure that is being presented as a result of the newly adopted standard.

Prior period amounts were not adjusted and continue to be reported in accordance with previous guidance.

Income Taxes

The Company uses the asset and liability method of accounting for income taxes. Under this method, income tax expense is recognized for the amount of taxes payable or refundable for the current period. The Company accrues for probable tax obligations as required by facts and circumstances in various regulatory environments. In addition, deferred tax assets and liabilities are recognized for expected future tax consequences of temporary differences between the financial reporting and tax basis of assets and liabilities. When appropriate, valuation allowances are recorded to reduce deferred tax assets to amounts for which realization is more likely than not.

Uncertain income tax positions taken or expected to be taken in tax returns are reflected within the Company’s financial statements based on a recognition and measurement process.


9




Earnings per Common Share

Basic earnings per common share is computed by dividing income available to common shareholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per common share is calculated using the weighted-average number of common shares outstanding and dilutive common shares, such as those issuable upon exercise of stock options and upon the vesting of restricted stock and restricted stock units.

Share-Based Compensation

The Company estimates the fair value of share-based awards on the date of grant using the Black-Scholes valuation model for stock options and using the share price on the date of grant for restricted stock and restricted stock units. The value of the award is recognized ratably as an expense in the Company’s Consolidated Statements of Comprehensive Income over the requisite service periods, with adjustments made for forfeitures as they occur.

Identifiable Intangible Assets and Goodwill

Identifiable intangible assets are amortized on a straight-line basis over their respective lives. Goodwill represents the excess of cost over the fair value of net assets of acquired businesses. Management reviews the carrying value of goodwill at least annually during the fourth quarter of each year to assess for impairment, or more often if events or circumstances indicate that the carrying value may exceed its estimated fair value. No  impairment loss was recognized on the Company’s intangible assets or goodwill during the six months ended June 30, 2018 .

Concentrations of Credit Risk

The financial instruments that are subject to concentrations of credit risk are cash and cash equivalents, marketable securities, deferred compensation funding and accounts and notes receivable. The Company’s marketable securities are fixed income investments which are highly liquid and can be readily purchased or sold through established markets. At June 30, 2018 and December 31, 2017 , substantially all of the Company’s cash and cash equivalents and marketable securities were held in one large financial institution located in the United States.

The Company’s clients are concentrated in the healthcare industry and are primarily providers of long-term care. The revenues of many of the Company’s clients are highly reliant on Medicare, Medicaid and third party payors’ reimbursement funding rates. New legislation or changes in existing regulations could directly impact the governmental reimbursement programs in which the clients participate. As a result, the Company may not know the full effects of such programs until these laws are fully implemented and governmental agencies issue applicable regulations or guidance.

Recent Accounting Pronouncements

In February 2016, the FASB issued Accounting Standards Update 2016-02,  Leases (“ASU 2016-02”). ASU 2016-02 requires lessees to recognize assets and liabilities on their balance sheet related to the rights and obligations created by most leases, while continuing to recognize expenses on their income statements over the lease term.  It will also require disclosures designed to give financial statement users information regarding the amount, timing, and uncertainty of cash flows arising from leases. The guidance is effective for annual reporting periods beginning after December 15, 2018, and interim periods within those years. Early adoption is permitted for all entities. The Company will adopt the new guidance as of January 1, 2019. The primary impact of ASU 2016-02 will relate to the capitalization of certain operating leases, however the Company does not expect the standard to have a material impact on the consolidated financial statements. The actual impact of the standard implementation will depend on the Company's lease portfolio at the time of adoption. The Company continues to assess all implications of the standard and related financial disclosures.

In January 2017, the FASB issued Accounting Standards Update 2017-04,  Simplifying the Test for Goodwill Impairment (“ASU 2017-04”). ASU 2017-04 no longer requires companies to perform a hypothetical purchase price allocation to measure impairment, eliminating step 2 of the goodwill impairment test. Instead, impairment will be measured using the difference of the carrying amount to the fair value of Goodwill on a reporting unit basis. The guidance is effective for annual reporting periods beginning after December 15, 2019, but early adoption is permitted. The Company has elected to early adopt ASU 2017-04 for the annual evaluation which will be performed during the fourth quarter of 2018.





10




Note 2—Revenue

The Company disaggregates its consolidated revenues by reportable segment, as Management evaluates the nature, amount, timing and uncertainty of the Company’s revenues by segment. Refer to Note 12—Segment Information herein as well as the information below regarding the Company’s reportable segments.

Housekeeping

Housekeeping accounted for approximately 48.9% , or $492.0 million , and 55.6% , or $486.3 million , of the Company’s consolidated revenues for the six months ended June 30, 2018 and 2017 , respectively. The services provided under this segment include managing clients’ housekeeping departments, which are principally responsible for the cleaning, disinfecting and sanitizing of resident rooms and common areas of the clients’ facilities, as well as the laundering and processing of the bed linens, uniforms, resident personal clothing and other assorted linen items utilized at the clients’ facilities. Upon beginning service with a client facility, the Company will typically hire and train the employees previously employed by such facility and assign an on-site manager to supervise and train the front-line personnel and coordinate housekeeping services with other facility support functions in accordance with client requests. Such management personnel also oversee the execution of various cost and quality control procedures including continuous training and employee evaluation, and on-site testing for infection control.

Dietary

Dietary services represented approximately 51.1% , or $513.6 million , and 44.4% , or $389.0 million , of the Company’s consolidated revenues for the six months ended June 30, 2018 and 2017 , respectively. Dietary services consist of managing clients’ dietary departments which are principally responsible for food purchasing, meal preparation and professional dietitian services, which include the development of menus that meet the dietary needs of residents. On-site management is responsible for all daily dietary department activities, with regular support being provided by a District Manager specializing in dietary services, as well as a registered dietitian. The Company also offers clinical consulting services to facilities which if contracted is a service bundled within the monthly service provided to clients. Upon beginning service with a client facility, the Company will typically hire and train the employees previously employed by such facility and assign an on-site manager to supervise and train the front-line personnel and coordinate dietitian services with other facility support functions in accordance with client requests. Such management personnel also oversee the execution of various cost- and quality-control procedures including continuous training and employee evaluation.

Revenue Recognition

Substantially all of the Company's revenues are derived from contracts with customers. The Company accounts for revenue from contracts with customers in accordance with ASC 606, and as such, the Company recognizes revenue to depict the transfer of promised goods and services to customers in amounts that reflect the consideration to which the Company expects to be entitled in exchange for those goods and services. The Company’s costs of obtaining contracts are not material.

The Company performs services and provides goods in accordance with contracts with its customers. Such contracts typically provide for a renewable one year service term, cancelable by either party upon 30 to 90 days ' notice, after an initial period of 60 to 120 days . A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is defined as the unit of account under ASC 606. The Company’s Housekeeping and Dietary contracts relate to the provision of bundles of goods, services or both, which represent a series of distinct goods and services and that are substantially the same and that have the same pattern of transfer to the customer. Accordingly, the Company accounts for the series as a single performance obligation satisfied over time, as the customer simultaneously receives and consumes the benefits of the goods and services provided. Revenue is recognized using the output method, which is based upon the delivery of goods and services to the clients’ facilities. In limited cases, the Company provides goods, services or both, before the execution of a written contract. In these cases, the Company defers the recognition of revenue until a contract is executed. The amount of such deferred revenue was not material as of and for the three and six months ended June 30, 2018 .

The transaction price is the amount of consideration to which the Company expects to be entitled in exchange for transferring promised goods or services to its customers. The transaction price does not include taxes assessed or collected. The Company’s contracts detail the fees that the Company charges for the goods and services it provides. For certain contracts which contain a variable component to the transaction price, the Company is required to make estimates of the amount of consideration to which the Company will be entitled, based on variability in resident and patient populations serviced, product usage or quantities consumed. The Company recognizes revenue related to such estimates only when Management determines that there will not be a significant reversal in the amount of revenue recognized. The Company’s contracts generally do not contain significant financing components, as the contracts contain payment terms that are less than one year.

11





The Company allocates the transaction price to each performance obligation, noting that the bundle of goods, services or goods and services provided under each Housekeeping and Dietary contract represents a single performance obligation that is satisfied over time. The Company recognizes the related revenue when it satisfies the performance obligation by transferring a bundle of promised goods, services or both to a customer. Such recognition is on a monthly or weekly basis, as goods are provided and services are performed. In some cases, the Company requires customers to pay in advance for goods and services to be provided. However, as of June 30, 2018 , the value of the associated contract liabilities was no t material.

Transaction Price Allocated to Remaining Performance Obligations

The Company recognizes revenue as it satisfies the performance obligations associated with contracts with customers, which due to the nature of the goods and services provided by the Company, are satisfied over time. Contracts may contain transaction prices that are fixed, variable or both. The significant majority of the Company’s contracts with customers have an initial term of one year or less, with renewable one year service terms, cancelable by either party upon 30 to 90 days ’ notice after an initial period of 60 to 120 days . For the purpose of disclosing the transaction price allocated to remaining performance obligations, the Company elected to apply practical expedients available under the guidance in ASC 606 to exclude from the calculation future revenues expected for the performance of services under contracts with variable consideration that are for a term of one year or less. Although only a small portion of the Company’s contracts have an original expected duration that exceeds 12 months , the Company has historically had, and expects to continue to have, favorable client retention rates. As of June 30, 2018 , the revenue expected to be recognized with the fixed transaction price associated with the remaining performance obligations under the Company’s existing contracts with a term greater than one year is $146.7 million for the remainder of 2018 , $293.5 million for 2019 , $293.6 million for 2020 , $293.7 million for 2021 , $291.2 million for 2022 and $363.8 million thereafter.

Note 3— Accounts and Notes Receivable

The Company’s accounts and notes receivable balances consisted of the following as of June 30, 2018 and December 31, 2017 :

 
June 30, 2018
 
December 31, 2017
 
(in thousands)
Short-term
 
 
 
Accounts and notes receivable
$
393,374

 
$
390,705

Allowance for doubtful accounts
(49,709
)
 
(11,985
)
 
$
343,665

 
$
378,720

Long-term
 
 
 
Notes receivable
$
37,386

 
$
15,476

Total accounts and notes receivable
$
381,051

 
$
394,196


Any decision to extend credit is made on a case-by-case basis and is based on a number of qualitative and quantitative factors related to the particular client, and general collection risks associated with operating within and trends in the long-term care industry.

The Company’s net current accounts and notes receivable balance decreased from December 31, 2017 . Fluctuations in net accounts and notes receivable are generally attributable to a variety of factors including, but not limited to, the timing of cash receipts from customers and the inception, transition or termination of client relationships. However, the Company offset its accounts and notes receivable with an increased allowance for doubtful accounts in the first quarter 2018 related primarily to corporate restructurings of two privately-held, multi-state operators that occurred during the first quarter 2018. In addition, the Company converted approximately $24.8 million of accounts receivable to long-term notes receivable, due to the achievement of key operational and financial milestones related to the 2017 dining and nutrition expansion with Genesis HealthCare.

There are a variety of factors that impact a client’s ability to pay in accordance with the Company’s agreements. Primary among these factors is the client’s participation in programs funded by federal and state governmental agencies. Deviations in the timing or amounts of reimbursements under those programs can impact the client’s cash flows and the timing of their payments. The payment terms in the Company’s service agreements are not contingent upon the client’s cash flows and notwithstanding the Company’s efforts to minimize credit risk exposure, various factors affecting the client’s cash flows could have an indirect, yet material adverse effect on the Company’s results of operations and financial condition.


12




The Company deploys significant resources and has invested in tools and processes to optimize Management’s credit and collections efforts. When appropriate, the Company utilizes interest-bearing promissory notes as an alternative to accounts receivable to enhance the collectability of amounts due, by instituting a definitive repayment plan and providing a means by which to further evidence the amounts owed. As of June 30, 2018 and December 31, 2017 , the Company had $59.4 million and $36.6 million , net of reserves, respectively, of such promissory notes outstanding. In addition, the Company may assist clients who are adjusting to changes in their cash flows by amending the Company’s agreements from full-service to management-only arrangements, or by modifying contractual payment terms to accommodate clients who have in good faith established clearly-defined plans for addressing cash flow issues. These efforts are intended to minimize the Company’s collections risk while maintaining relationships with the clients.

Note 4— Allowance for Doubtful Accounts

The allowance for doubtful accounts is established when the Company determines that it is probable that receivables have been impaired and the Company can reasonably estimate the amount of the losses. The related provision for bad debts is charged to costs of services provided in the Company’s Consolidated Statements of Comprehensive Income. The allowance for doubtful accounts is evaluated based on the Company’s ongoing review of accounts and notes receivable and is inherently subjective as it requires estimates susceptible to significant revision as more information becomes available.

The Company has had varying collections experience with respect to its accounts and notes receivable. The Company has sometimes extended the period of payment for certain clients beyond contractual terms. Such clients include those who have terminated service agreements and slow payers experiencing financial difficulties. In order to provide for such collection issues and the general risk associated with the granting of credit terms, the Company recorded bad debt provisions (in Allowance for Doubtful Accounts) of $39.4 million and $2.1 million for the six months ended June 30, 2018 and 2017 , respectively. The increase in the provision for bad debts period-over-period is primarily related to corporate restructurings of two privately-held, multi-state operators that occurred during the first quarter 2018.

In making the Company’s credit evaluations, in addition to analyzing and anticipating, where possible, the specific cases described above, management considers the general collection risk associated with trends in the long-term care industry. The Company establishes credit limits, performs ongoing credit evaluations and monitors accounts to minimize the risk of loss. Despite the Company’s efforts to minimize credit risk exposure, clients could be adversely affected if future industry trends change in such a manner as to negatively impact their cash flows. If the Company’s clients experience a negative impact on their cash flows, it could have a material adverse effect on the Company’s results of operations and financial condition.

Note 5—Changes in Accumulated Other Comprehensive Income by Component

Accumulated other comprehensive income consists of unrealized gains and losses from the Company’s available-for-sale marketable securities. The following table provides a summary of the changes in accumulated other comprehensive income for the six months ended June 30, 2018 and 2017 :
 
Unrealized Gains and Losses on Available-for-Sale Securities (1)
 
Six Months Ended June 30,
 
2018
 
2017
 
(in thousands)
Accumulated other comprehensive income (loss) — beginning balance
$
837

 
$
(319
)
Other comprehensive (loss) income before reclassifications
(1,167
)
 
963

Losses reclassified from other comprehensive income (2)
126

 
118

Net current period other comprehensive (loss) income (3)
(1,041
)
 
1,081

Accumulated other comprehensive (loss) income — ending balance
$
(204
)
 
$
762


(1)  
All amounts are net of tax.
(2)  
Realized losses were recorded pre-tax under “Other income, net - Investment and interest” in our Consolidated Statements of Comprehensive Income. For the  six months ended June 30, 2018  and  2017 , the Company recorded $0.2 million of realized losses from the sale of available-for-sale securities. Refer to Note 8—Fair Value Measurements herein for further information.
(3)  
For the six months ended June 30, 2018 and 2017 , the changes in other comprehensive income were net of a tax benefit of $0.3 million and an expense of $0.6 million , respectively.


13




 
Amounts Reclassified from Accumulated Other Comprehensive Income
 
2018
 
2017
 
(in thousands)
Three Months Ended June 30,
 
 
 
Losses from the sale of available-for-sale securities
$
(67
)
 
$
(125
)
Tax benefit
11

 
40

Net loss reclassified from accumulated other comprehensive income
$
(56
)
 
$
(85
)
Six Months Ended June 30,
 
 
 
Losses from the sale of available-for-sale securities
$
(156
)
 
$
(173
)
Tax benefit
30

 
55

Net loss reclassified from accumulated other comprehensive income
$
(126
)
 
$
(118
)

Note 6—Property and Equipment

Property and equipment are recorded at cost. Depreciation is recorded over the estimated useful life of each class of depreciable asset, and is computed using the straight-line method. Leasehold improvements are amortized over the shorter of the estimated asset life or term of the lease. Repairs and maintenance costs are charged to expense as incurred.

The following table sets forth the amounts of property and equipment by each class of depreciable asset as of June 30, 2018 and December 31, 2017 :
 
June 30, 2018
 
December 31, 2017
 
(in thousands)
Housekeeping and Dietary equipment
$
22,753

 
$
22,349

Computer hardware and software
12,570

 
12,665

Other (1)
988

 
990

Total property and equipment, at cost
36,311

 
36,004

Less accumulated depreciation
23,057

 
22,495

Total property and equipment, net
$
13,254

 
$
13,509


(1)  
Includes furniture and fixtures, leasehold improvements and autos and trucks.

Depreciation expense for each of the three months ended June 30, 2018 and 2017 was $1.3 million . Depreciation expense for each of the six months ended June 30, 2018 and 2017 was $2.6 million .

Note 7—Other Intangible Assets

The Company’s other intangible assets consist of customer relationships which were obtained through acquisitions and are recorded at their fair values at the date of acquisition. Intangible assets with determinable lives are amortized on a straight-line basis over their estimated useful lives. The customer relationships have a weighted-average amortization period of approximately 10 years .


14




The following table sets forth the estimated amortization expense for intangibles subject to amortization for the remainder of 2018 , the following five fiscal years and thereafter:
Period/Year
 
Total Amortization Expense
 
 
 
(in thousands)
 
July 1 to December 31, 2018
 
$
2,133

 
2019
 
$
4,165

 
2020
 
$
4,165

 
2021
 
$
4,165

 
2022
 
$
4,165

 
2023
 
$
3,168

 
Thereafter
 
$
6,689

 

Amortization expense for the three months ended June 30, 2018 and 2017 was $1.1 million , respectively. Amortization expense for the six months ended June 30, 2018 and 2017 was $2.2 million and $1.7 million , respectively.

Note 8—Fair Value Measurements

The Company’s current assets and current liabilities are financial instruments and most of these items (other than marketable securities and inventories) are recorded at cost in the Consolidated Balance Sheets. The estimated fair value of these financial instruments approximates their carrying value due to their short-term nature. The carrying value of the Company’s line of credit represents the outstanding amount of the borrowings, which approximates fair value. The Company’s financial assets that are measured at fair value on a recurring basis are its marketable securities and deferred compensation funding. The recorded values of all of the financial instruments approximate their current fair values because of their nature, stated interest rates and respective maturity dates or durations.

The Company’s marketable securities consist of tax-exempt municipal bonds, which are classified as available-for-sale and are reported at fair value. Unrealized gains and losses associated with these investments are included in other comprehensive income (net of tax) within the Consolidated Statements of Comprehensive Income. The fair value of these marketable securities is classified within Level 2 of the fair value hierarchy, as these securities are measured using quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable. Such valuations are determined by a third-party pricing service. For the three months ended June 30, 2018 and 2017 , the Company recorded unrealized gains of $0.1 million and $0.6 million on marketable securities, respectively. For the six months ended June 30, 2018 and 2017 , the Company recorded unrealized losses of $1.0 million and unrealized gains of $1.1 million on marketable securities, respectively.

For the three months ended June 30, 2018 and 2017 , the Company received total proceeds, less the amount of interest received, of $3.3 million and $7.0 million , respectively, from sales of available-for-sale municipal bonds. For the three months ended June 30, 2018 and 2017 , these sales resulted in realized losses of $0.1 million for each period. For the six months ended June 30, 2018 and 2017 , the Company received total proceeds, less the amount of interest received, of $5.8 million and $14.7 million , respectively, from sales of available-for-sale municipal bonds. For the six months ended June 30, 2018 and 2017 , these sales resulted in realized losses of $0.2 million for each period which were recorded in “Other income, net – Investment and interest” in the Consolidated Statements of Comprehensive Income. The basis for the sale of these securities was the specific identification of each bond sold during the period.


15




The investments under the funded deferred compensation plan are accounted for as trading securities and unrealized gains or losses are included in earnings. The fair value of these investments are determined based on quoted market prices (Level 1).

The following tables provide fair value measurement information for the Company’s marketable securities and deferred compensation fund investments as of June 30, 2018 and December 31, 2017 :
 
As of June 30, 2018
 
 
 
 
 
Fair Value Measurement Using:
 
Carrying Amount
 
Total Fair Value
 
Quoted Prices in Active Markets (Level 1)
 
Significant Other Observable Inputs (Level 2)
 
Significant Unobservable Inputs (Level 3)
 
(in thousands)
Financial Assets:
 
 
 
 
 
 
 
 
 
Marketable securities
 
 
 
 
 
 
 
 
 
Municipal bonds — available-for-sale
$
74,928

 
$
74,928

 
$

 
$
74,928

 
$

 
 
 
 
 
 
 
 
 
 
Deferred compensation fund
 
 
 
 
 
 
 
 
 
Money Market  (1)
$
2,347

 
$
2,347

 
$

 
$
2,347

 
$

Balanced and Lifestyle
8,681

 
8,681

 
8,681

 

 

Large Cap Growth
8,898

 
8,898

 
8,898

 

 

Small Cap Growth
3,667

 
3,667

 
3,667

 

 

Fixed Income
3,345

 
3,345

 
3,345

 

 

International
1,644

 
1,644

 
1,644

 

 

Mid Cap Growth
2,115

 
2,115

 
2,115

 

 

Deferred compensation fund
$
30,697

 
$
30,697

 
$
28,350

 
$
2,347

 
$



16




 
As of December 31, 2017
 
 
 
 
 
Fair Value Measurement Using:
 
Carrying
Amount
 
Total Fair
Value
 
Quoted Prices in Active Markets (Level 1)
 
Significant Other Observable Inputs (Level 2)
 
Significant Unobservable Inputs (Level 3)
 
(in thousands)
Financial Assets:
 
 
 
 
 
 
 
 
 
Marketable securities
 
 
 
 
 
 
 
 
 
Municipal bonds — available-for-sale
$
73,221

 
$
73,221

 
$

 
$
73,221

 
$

 
 
 
 
 
 
 
 
 
 
Deferred compensation fund
 
 
 
 
 
 
 
 
 
Money Market (1)
$
2,720

 
$
2,720

 
$

 
$
2,720

 
$

Balanced and Lifestyle
8,523

 
8,523

 
8,523

 

 

Large Cap Growth
7,802

 
7,802

 
7,802

 

 

Small Cap Growth
3,442

 
3,442

 
3,442

 

 

Fixed Income
3,050

 
3,050

 
3,050

 

 

International
1,531

 
1,531

 
1,531

 

 

Mid Cap Growth
1,817

 
1,817

 
1,817

 

 

Deferred compensation fund
$
28,885

 
$
28,885

 
$
26,165

 
$
2,720

 
$


(1)  
The fair value of the money market fund is based on the net asset value (“NAV”) of the shares held by the plan at the end of the period. The money market fund includes short-term United States dollar denominated money market instruments and the NAV is determined by the custodian of the fund. The money market fund can be redeemed at its NAV at the measurement date as there are no significant restrictions on the ability to sell this investment.

Amortized Cost
 
Gross Unrealized Gains
 
Gross Unrealized Losses
 
Estimated Fair Value
 
Other-than-temporary Impairments
 
(in thousands)
June 30, 2018
 
 
 
 
 
 
 
 
 
Type of security:
 
 
 
 
 
 
 
 
 
Municipal bonds — available-for-sale
$
75,273

 
$
347

 
$
(692
)
 
$
74,928

 
$

Total debt securities
$
75,273

 
$
347

 
$
(692
)
 
$
74,928

 
$

 
 
 
 
 
 
 
 
 
 
December 31, 2017
 
 
 
 
 
 
 
 
 
Type of security:
 
 
 
 
 
 
 
 
 
Municipal bonds — available-for-sale
$
72,249

 
$
1,169

 
$
(197
)
 
$
73,221

 
$

Total debt securities
$
72,249

 
$
1,169

 
$
(197
)
 
$
73,221

 
$


The following table summarizes the contractual maturities of debt securities held at June 30, 2018 and December 31, 2017 , which are classified as marketable securities in the Consolidated Balance Sheets:
 
 
Municipal Bonds — Available-for-Sale
Contractual maturity:
 
June 30, 2018
 
December 31, 2017
 
 
(in thousands)
Maturing in one year or less
 
$
1,412

 
$
916

Maturing in second year through fifth year
 
19,067

 
15,948

Maturing in sixth year through tenth year
 
18,737

 
22,851

Maturing after ten years
 
35,712

 
33,506

Total debt securities
 
$
74,928

 
$
73,221



17




Note 9— Stock-Based Compensation

The components of the Company’s stock-based compensation expense for the six months ended June 30, 2018 and 2017 are as follows:
 
Six Months Ended June 30,
 
2018
 
2017
 
(in thousands)
Stock options
$
1,514

 
$
2,040

Restricted stock and restricted stock units
1,292

 
584

Employee Stock Purchase Plan
289

 
249

Total pre-tax stock-based compensation expense charged against income (1)
$
3,095

 
$
2,873


(1)  
Stock-based compensation expense is recorded in selling, general and administrative expense in the Company’s Consolidated Statements of Comprehensive Income.

At June 30, 2018 , the unrecognized compensation cost related to unvested stock options and awards was $17.1 million . The weighted average period over which these awards will vest is approximately 3.0 years.

2012 Equity Incentive Plan

The Company’s Second Amended and Restated 2012 Equity Incentive Plan (the “Plan”) provides that current or prospective officers, employees, non-employee directors and advisors can receive share-based awards such as stock options, restricted stock, restricted stock units and other stock awards. The Plan seeks to promote the highest level of performance by providing an economic interest in the long-term success of the Company.

As of June 30, 2018 , 3.0 million  shares of common stock were reserved for issuance under the Plan, including 0.5 million shares available for future grant. No stock award will have a term in excess of ten years. All awards granted under the Plan become vested and exercisable ratably over a five year period on each yearly anniversary of the grant date.

The Nominating, Compensation and Stock Option Committee of the Board of Directors is responsible for determining the terms of the grants in accordance with the Plan.

Stock Options

A summary of stock options outstanding under the Plan as of December 31, 2017 and changes during the six months ended June 30, 2018 is as follows:
 
Stock Options Outstanding
 
Number of Shares
 
Weighted Average Exercise Price
 
(in thousands)
 
 
December 31, 2017
2,374

 
$
29.22

Granted
169

 
$
52.06

Exercised
(208
)
 
$
27.62

Forfeited
(46
)
 
$
35.41

Expired
(1
)
 
$
36.49

June 30, 2018
2,289

 
$
30.92


The weighted average grant-date fair value of stock options granted during the six months ended June 30, 2018 and 2017 was $10.48 and $8.52 per common share, respectively. The total intrinsic value of options exercised during the six months ended June 30, 2018 and 2017 was $4.7 million and $7.0 million , respectively.


18




The fair value of stock option awards granted in 2018 and 2017 was estimated on the date of grant using the Black-Scholes option valuation model with the following assumptions:
 
Six Months Ended June 30,
 
2018
 
2017
Risk-free interest rate
2.1
%
 
2.0
%
Weighted average expected life
5.8 years

 
5.8 years

Expected volatility
21.4
%
 
25.1
%
Dividend yield
1.5
%
 
1.9
%

The following table summarizes other information about the stock options at June 30, 2018 :
 
June 30, 2018
 
(amounts in thousands, except per share data)
Outstanding:
 
Aggregate intrinsic value
$
29,557

Weighted average remaining contractual life
6.3 years

Exercisable:
 
Number of options
1,199

Weighted average exercise price
$
24.76

Aggregate intrinsic value
$
22,103

Weighted average remaining contractual life
4.9 years


Restricted Stock Units and Restricted Stock

The fair value of outstanding restricted stock units and restricted stock was determined based on the market price of the shares on the date of grant. During the six months ended June 30, 2018 , the Company granted 139 thousand restricted stock units with a weighted average grant date fair value of $52.06 per unit. During the six months ended June 30, 2017 , the Company granted 81 thousand restricted stock units with a weighted average grant date fair value of $39.38 per share.

During the six months ended June 30, 2018 and 2017, the Company did no t grant any restricted stock.

A summary of the outstanding restricted stock units and restricted stock as of December 31, 2017 and changes during the six months ended June 30, 2018 is as follows:
 
Restricted Stock Units and Restricted Stock
 
Number
 
Weighted Average Grant Date Fair Value
 
(in thousands)
 
 
December 31, 2017
145

 
$
37.07

Granted
139

 
$
52.06

Vested
(34
)
 
$
35.16

Forfeited
(4
)
 
$
52.06

June 30, 2018
246

 
$
45.58


Employee Stock Purchase Plan

The Company's Employee Stock Purchase Plan ("ESPP") is currently available through 2021 to all eligible employees. All full-time and part-time employees who work an average of 20 hours per week and have completed two years of continuous service with the Company are eligible to participate. Annual offerings commence and terminate on the respective year’s first and last calendar day.

Under the ESPP, the Company is authorized to issue up to 4.1 million shares of its common stock to its employees. Pursuant to such authorization, there are 2.3 million shares available for future grant at June 30, 2018 .

19





The expense associated with the options granted under the ESPP during the six months ended June 30, 2018 and 2017 was estimated on the date of grant using the Black-Scholes option valuation model with the following assumptions:
 
Six Months Ended June 30,
 
2018
 
2017
Risk-free interest rate
1.89%
 
1.05%
Weighted average expected life (years)
1.0
 
1.0
Expected volatility
20.8%
 
21.2%
Dividend yield
1.4%
 
1.9%

Deferred Compensation Plan

The Company offers a Supplemental Executive Retirement Plan (“SERP”) for executives and certain key employees. The SERP allows participants to defer a portion of their earned income on a pre-tax basis and as of the last day of each plan year, each participant will be credited with a match of a portion of their deferral in the form of the Company’s common stock based on the then-current market value. Under the SERP, the Company is authorized to issue 1.0 million shares of its common stock to its employees. Pursuant to such authorization, the Company has 0.4 million shares available for future grant at June 30, 2018 . At the time of issuance, such shares are accounted for at cost as treasury stock.

The following table summarizes information about the SERP during the six months ended June 30, 2018 and 2017 :
 
Six Months Ended June 30,
 
2018
 
2017
 
(in thousands)
SERP expense  (1)
$
328

 
$
308

Unrealized gain recorded in SERP liability account
$
1,118

 
$
2,313


(1)  
Both the SERP match and the deferrals are included in the selling, general and administrative caption in the Consolidated Statements of Comprehensive Income.

Note 10— Dividends

During the six months ended June 30, 2018 , the Company paid regular quarterly cash dividends totaling approximately $28.4 million as follows:
 
Quarter Ended
 
March 31, 2018
 
June 30, 2018
 
(in thousands, except per share data)
Cash dividend paid per common share
$
0.19125

 
$
0.19250

Total cash dividends paid
$
14,149

 
$
14,249

Record date
February 16, 2018

 
May 25, 2018

Payment date
March 23, 2018

 
June 29, 2018


Additionally, on July 17, 2018 , the Company’s Board of Directors declared a regular quarterly cash dividend of $0.19375 per common share, which will be paid on September 28, 2018 , to shareholders of record as of the close of business on August 24, 2018 .

Cash dividends declared for the periods presented were as follows:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2018
 
2017
 
2018
 
2017
Cash dividends declared per common share
$
0.19375

 
$
0.18875

 
$
0.38625

 
$
0.37625



20




Note 11— Income Taxes

On December 22, 2017, the U.S. enacted the Tax Cuts and Jobs Act (the “Act”), which significantly changed U.S. tax law. The Act lowered the Company’s U.S. statutory federal income tax rate from 35% to 21% effective January 1, 2018. Year to date, the Company has recognized a provision for income taxes of  $6.0 million .

The 2018 estimated annual effective tax rate is expected to be approximately 21% to 23% . The actual annual effective tax rate will be impacted by the tax effects of option exercises or vested awards, which are treated as discrete items in the reporting period in which they occur, and therefore cannot be considered in the calculation of the estimated annual effective tax rate. The impact on the Company’s income tax provision for the six months ended June 30, 2018 for such discrete items was approximately $1.1 million .

Differences between the effective tax rate and the applicable U.S. federal statutory rate arise primarily from the effect of state and local income taxes, share-based compensation and tax credits available to the Company. The actual 2018 effective tax rate will likely vary from the estimate depending on the availability of tax credits and the exercise of stock options and vesting of share-based awards.

The Company accounts for income taxes using the asset and liability method, which results in recognizing income tax expense based on the amount of income taxes payable or refundable for the current year. Additionally, the Company regularly evaluates the tax positions taken or expected to be taken resulting from financial statement recognition of certain items. Based on the evaluation, there are no significant uncertain tax positions requiring recognition in the Company’s financial statements. The evaluation was performed for the tax years ended December 31, 2013 through 2017 (with regard to U.S. federal income tax returns) and December 31, 2012 through 2017 (with regard to various state and local income tax returns), the tax years which remain subject to examination by major tax jurisdictions as of June 30, 2018 .

The Company may from time to time be assessed interest or penalties by taxing jurisdictions, although any such assessments historically have been minimal and immaterial to its financial results. When the Company has received an assessment for interest and/or penalties, it will be classified in the financial statements as selling, general and administrative expense. In addition, any interest or penalties relating to recognized uncertain tax positions would also be recorded in selling, general and administrative expense.

Note 12—Segment Information

The Company manages and evaluates its operations in two reportable segments: Housekeeping (housekeeping, laundry, linen and other services) and Dietary (dietary department services). Although both segments serve the same client base and share many operational similarities, they are managed separately due to distinct differences in the type of services provided, as well as the specialized expertise required of the professional management personnel responsible for delivering each segment’s services. Such services are rendered pursuant to discrete service agreements, specific to each reportable segment.


21




The Company’s accounting policies for the segments are generally the same as described in the Company’s significant accounting policies. Differences between the reportable segments’ operating results and other disclosed data and the information in the consolidated financial statements relate primarily to corporate level transactions and recording of transactions at the reportable segment level using other than generally accepted accounting principles. There are certain inventories and supplies that are primarily expensed when incurred within the operating segments, while they are capitalized in the consolidated financial statements. In addition, most corporate expenses such as corporate salary and benefit costs, certain legal costs, bad debt expense, information technology costs, depreciation, amortization of finite-lived intangible assets, share based compensation costs and other corporate-specific costs, are not allocated to the operating segments. There are also allocations for workers’ compensation and general liability expense within the operating segments that differ from the actual expense recorded by the Company under U.S. GAAP. Segment amounts disclosed are prior to elimination entries made in consolidation.
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2018
 
2017
 
2018
 
2017
 
(in thousands)
Revenues
 
 
 
 
 
 
 
Housekeeping
$
245,547

 
$
242,919

 
$
491,956

 
$
486,342

Dietary
258,185

 
227,957

 
513,586

 
389,024

Total
$
503,732

 
$
470,876

 
$
1,005,542

 
$
875,366

 
 
 
 
 
 
 
 
Income before income taxes
 
 
 
 
 
 
 
Housekeeping
$
29,078

 
$
21,474

 
$
58,015

 
$
44,676

Dietary
15,571

 
13,142

 
30,301

 
23,367

Corporate and eliminations (1)
(11,333
)
 
(1,538
)
 
(56,395
)
 
(2,686
)
Total
$
33,316

 
$
33,078

 
$
31,921

 
$
65,357

(1)  
Primarily represents corporate office costs and related overhead, recording of certain inventories and supplies and workers compensation costs at the reportable segment level which use accounting methods that differ from those used at the corporate level, as well as consolidated subsidiaries’ operating expenses that are not allocated to the reportable segments, net of investment and interest income. It is also inclusive of charges recorded to provision to bad debt during the first quarter of 2018 as a result of restructuring events primarily from two customers that occurred during the six months ended June 30, 2018 . No such charges were recorded for the three months ended June 30, 2018 .

Note 13— Earnings Per Common Share

Basic and diluted earnings per common share are computed by dividing net income by the weighted-average number of basic and diluted common shares outstanding, respectively. The weighted-average number of diluted common shares includes the impact of dilutive securities, including outstanding stock options and unvested restricted stock and restricted stock units. The table below reconciles the weighted-average basic and diluted common shares outstanding:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2018
 
2017
 
2018
 
2017
 
(in thousands)
Weighted average number of common shares outstanding - basic
73,982

 
73,276

 
73,947

 
73,176

Effect of dilutive securities  (1)
505

 
993

 
659

 
932

Weighted average number of common shares outstanding - diluted
74,487

 
74,269

 
74,606

 
74,108


(1)
Certain outstanding stock option awards are anti-dilutive and were therefore excluded from the calculation of the weighted average number of diluted common shares outstanding. During the three and six months ended June 30, 2018 , options to purchase 0.7 million and 0.6 million shares having a weighted average exercise price of $42.16 and $42.66 per share were excluded. During the three and six months ended June 30, 2017 , options to purchase 0.5 million shares having a weighted average exercise price of $39.38 per share were excluded.


22




Note 14— Other Contingencies

Line of Credit

At June 30, 2018 , the Company had a $300 million bank line of credit on which to draw for general corporate purposes. Amounts drawn under the line of credit are payable upon demand and generally bear interest at LIBOR plus  75 basis points . At June 30, 2018 , there were $40.5 million in borrowings under the line of credit. The line of credit requires the Company to satisfy one financial covenant, with which the Company is in compliance as of June 30, 2018 and expects to remain in compliance. The line of credit expires on December 18, 2018 , and although no assurances can be provided that the Company will renew the line of credit or secure other financing, the Company expects the line of credit to be renewed prior to expiration, or substituted with another form of financing.

At June 30, 2018 , the Company also had outstanding $65.9 million in irrevocable standby letters of credit, which relate to payment obligations under the Company's insurance programs. In connection with the issuance of the letters of credit, the amount available under the line of credit was reduced by $65.9 million to $193.6 million at June 30, 2018 .

Tax Jurisdictions and Matters

The Company provides services throughout the continental United States and is subject to numerous state and local taxing jurisdictions. In the ordinary course of business, a jurisdiction may contest the Company’s reporting positions with respect to the application of its tax code to the Company’s services, which could result in additional tax liabilities.

The Company has tax matters with various taxing authorities. Because of the uncertainties related to both the probable outcomes and amount of probable assessments due, the Company is unable to make a reasonable estimate of a liability. The Company does not expect the resolution of any of these matters, taken individually or in the aggregate, to have a material adverse effect on the consolidated financial position or results of operations based on the Company’s best estimate of the outcomes of such matters.

Legal Proceedings

The Company is subject to various claims and legal actions in the ordinary course of business. Some of these matters include payroll and employee-related matters and examinations by governmental agencies. As the Company becomes aware of such claims and legal actions, the Company records accruals for any exposures that are probable and estimable. If adverse outcomes of such claims and legal actions are reasonably possible, Management assesses materiality and provides financial disclosure, as appropriate. The Company believes it is not a party to, nor are any of its properties the subject of, any pending legal proceeding or governmental examination that would have a material adverse effect on the Company’s consolidated financial condition or liquidity.

Government Regulations

The Company’s clients are concentrated in the healthcare industry and are primarily providers of long-term care. The revenues of many of the Company’s clients are highly reliant on Medicare, Medicaid and third party payors’ reimbursement funding rates. New legislation or additional changes in existing regulations could directly impact the governmental reimbursement programs in which the clients participate. The full effect of any such programs would not be realized until these laws are fully implemented and government agencies issue applicable regulations or guidance.

Note 15—Subsequent Events

The Company evaluated all subsequent events through the filing date of this Form 10-Q. There were no events or transactions occurring during this subsequent reporting period which require recognition or additional disclosure in these financial statements.


23




Item 2.   Management’s Discussion and Analysis of Financial Condition and Results of Operations

Results of Operations

The following discussion is intended to provide the reader with information that will be helpful in understanding our financial statements, including the changes in certain key items when comparing financial statements period to period. We also intend to provide the primary factors that accounted for those changes, as well as a summary of how certain accounting principles affect our financial statements. In addition, we are providing information about the financial results of our two operating segments to further assist in understanding how these segments and their results affect our consolidated results of operations. This discussion should be read in conjunction with our financial statements as of June 30, 2018 and December 31, 2017 and the notes accompanying those financial statements.

Overview

We provide management, administrative and operating expertise and services to the housekeeping, laundry, linen, facility maintenance and dietary service departments of healthcare facilities, including nursing homes, retirement complexes, rehabilitation centers and hospitals located throughout the United States. We believe we are the largest provider of housekeeping and laundry management services to the long-term care industry in the nation, rendering such services to over 3,500 facilities throughout the continental United States as of June 30, 2018 .

We provide services primarily pursuant to full service agreements with our clients. Under such agreements, we are responsible for the day-to-day management of the employees located at our clients’ facilities, as well as for the provision of certain supplies. We also provide services on the basis of management-only agreements for a limited number of clients. Under a management-only agreement, we provide management and supervisory services while the client facility retains payroll responsibility for the non-supervisory staff. Our agreements with clients typically provide for a renewable one year service term, cancelable by either party upon 30 to 90 days’ notice after an initial period of 60 to 120 days.

We are organized into two reportable segments: housekeeping, laundry, linen and other services (“Housekeeping”), and dietary department services (“Dietary”).

Housekeeping consists of managing our clients’ housekeeping departments, which are principally responsible for the cleaning, disinfecting and sanitizing of resident rooms and common areas of the clients’ facilities, as well as the laundering and processing of the bed linens, uniforms, resident personal clothing and other assorted linen items utilized at the clients’ facilities. Upon beginning service with a client facility, we will typically hire and train the employees previously employed by such facility and assign an on-site manager to supervise and train the front-line personnel and coordinate housekeeping services with other facility support functions in accordance with client requests. Such management personnel also oversee the execution of various cost and quality control procedures including continuous training and employee evaluation, and on-site testing for infection control.

Dietary consists of managing our clients’ dietary departments, which are principally responsible for food purchasing, meal preparation and professional dietitian services, which include the development of menus that meet the dietary needs of residents. On-site management is responsible for all daily dietary department activities, with regular support being provided by a District Manager specializing in dietary services, as well as a registered dietitian. We also offer clinical consulting services to facilities which if contracted is a service bundled within the monthly service provided to clients. Upon beginning service with a client facility, we will typically hire and train the employees previously employed by such facility and assign an on-site manager to supervise and train the front-line personnel and coordinate dietitian services with other facility support functions in accordance with client requests. Such management personnel also oversee the execution of various cost- and quality-control procedures including continuous training and employee evaluation.

At June 30, 2018 , Housekeeping services were provided at essentially all of our more than 3,500 client facilities, generating approximately 48.9% or $492.0 million of our total revenues for the six months ended June 30, 2018 . Dietary services were provided to over 1,500 client facilities at June 30, 2018 and contributed approximately 51.1% or $513.6 million of our total revenues for the six months ended June 30, 2018 .

Subject to the factors noted in the Cautionary Statement Regarding Forward Looking Statements included in this Quarterly Report on Form 10-Q, and although there can be no assurance thereof, we expect our consolidated revenues for the remainder of 2018 to continue to grow. We expect that Dietary revenues will continue to grow as a percentage of consolidated revenue and such growth is expected to come from extending our Dietary department service offerings to our current Housekeeping client base. Growth in Housekeeping is expected to primarily come from obtaining new clients.


24



Table of Contents

Three Months Ended June 30, 2018 and 2017

The following table summarizes the income statement key components that we use to evaluate our financial performance on a consolidated and reportable segment basis, for the three months ended June 30, 2018 and 2017 . The differences between the reportable segments’ operating results and other disclosed data and our consolidated financial results relate primarily to corporate level transactions and adjustments related to transactions recorded at the reportable segment level which use methods other than generally accepted accounting principles.
 
Three Months Ended June 30,
 
2018
 
2017
 
% Change
 
(in thousands)
 
 
Revenues
 
 
 
 
 
Housekeeping
$
245,547

 
$
242,919

 
1.1
 %
Dietary
258,185

 
227,957

 
13.3
 %
Consolidated
$
503,732

 
$
470,876

 
7.0
 %
 
 
 
 
 
 
Costs of services provided
 
 
 
 
 
Housekeeping
$
216,469

 
$
221,445

 
(2.2
)%
Dietary
242,614

 
214,815

 
12.9
 %
Corporate and eliminations
(21,465
)
 
(28,938
)
 
(25.8
)%
Consolidated
$
437,618

 
$
407,322

 
7.4
 %
 
 
 
 
 
 
Selling, general and administrative expense
 
 
 
 
 
Corporate and eliminations
$
34,118

 
$
31,991

 
6.6
 %
 
 
 
 
 
 
Investment and interest income
 
 
 
 
 
Corporate and eliminations
$
1,320

 
$
1,515

 
(12.9
)%
 
 
 
 
 
 
Income (loss) before income taxes
 
 
 
 
 
Housekeeping
$
29,078

 
$
21,474

 
35.4
 %
Dietary
15,571

 
13,142

 
18.5
 %
Corporate and eliminations
(11,333
)
 
(1,538
)
 
636.9
 %
Consolidated
$
33,316

 
$
33,078

 
0.7
 %

Housekeeping revenues represented approximately 48.7% of consolidated revenues for the three months ended June 30, 2018 . Dietary revenues represented approximately 51.3% of consolidated revenues for the three months ended June 30, 2018 .

The following table sets forth the ratio which certain items bear to consolidated revenues:
 
Three Months Ended June 30,
 
2018
 
2017
Revenues
100.0
%
 
100.0
%
Operating costs and expenses:
 
 
 
Costs of services provided
86.9
%
 
86.5
%
Selling, general and administrative expense
6.8
%
 
6.8
%
Investment and interest income
0.3
%
 
0.3
%
Income before income taxes
6.6
%
 
7.0
%
Income taxes
1.5
%
 
2.2
%
Net income
5.1
%
 
4.8
%


25



Table of Contents

Revenues

Consolidated

Consolidated revenues increased 7.0% to $503.7 million for the three months ended June 30, 2018 compared to $470.9 million for the corresponding period in 2017 , as a result of the factors discussed below under Reportable Segments.

Reportable Segments

Housekeeping’s 1.1% net growth in reportable segment revenues resulted from service agreements entered into with new clients. Dietary’s 13.3% net growth in reportable segment revenues resulted primarily from providing these services to existing Housekeeping clients.

Costs of Services Provided

Consolidated

Consolidated costs of services provided increased 7.4% to $437.6 million for the three months ended June 30, 2018 compared to $407.3 million for the three months ended June 30, 2017 , which is primarily related to our 7.0% growth in consolidated revenues for the same period. As a percentage of consolidated revenues, costs of services provided increased to 86.9% in the three months ended June 30, 2018 from 86.5% in the corresponding period in 2017 .

Certain significant components within our costs of services provided are subject to fluctuation with changes in our business and client base. Labor and other labor-related costs, dining and housekeeping supplies, and self-insurance costs account for most of our consolidated costs of services provided. See the discussion under Reportable Segments below for additional information on the changes in the components of costs of services provided.

The following table provides a comparison of key indicators we consider when managing the consolidated costs of services provided:
 
 
Three Months Ended June 30,
Costs of Services Provided - Key Indicators as a % of Consolidated Revenue
 
2018
 
2017
 
Change
Bad debt provision
 
0.4%
 
0.2%
 
0.2%
Self-insurance costs
 
2.7%
 
2.8%
 
(0.1)%

The increase in the bad debt provision is related to the first quarter 2018 increase to the accounts receivable allowance, which was primarily related to the corporate restructuring of two privately-held multi-state operators.

Reportable Segments

Costs of services provided for Housekeeping, as a percentage of Housekeeping revenues, decreased to 88.2% for the three months ended June 30, 2018 from 91.2% in the corresponding period in 2017 . Costs of services provided for Dietary, as a percentage of Dietary revenues, decreased to 94.0% for the three months ended June 30, 2018 from 94.2% in the corresponding period in 2017 .

The following table provides a comparison of the key indicators we consider when managing costs of services provided at the segment level, as a percentage of the respective segment’s revenues:
 
 
Three Months Ended June 30,
Costs of Services Provided - Key Indicators as a % of Segment Revenue
 
2018
 
2017
 
Change
Housekeeping labor and other labor-related costs
 
78.2%
 
80.5%
 
(2.3)%
Housekeeping supplies
 
7.9%
 
8.1%
 
(0.2)%
Dietary labor and other labor-related costs
 
57.8%
 
54.8%
 
3.0%
Dietary supplies
 
33.9%
 
37.6%
 
(3.7)%

Variations within these key indicators relate to the provision of services at new facilities and changes in the mix of clients for whom we provide supplies or do not provide supplies. Management focuses on building efficiencies and managing labor and other costs at the facility level, as well as managing supply chain costs, for new and existing facilities.

26



Table of Contents


Consolidated Selling, General and Administrative Expense  

Excluding the change in the deferred compensation plan described below, consolidated selling, general and administrative expense increased $2.4 million or 7.8% during the three months ended June 30, 2018 compared to corresponding period in 2017 , related primarily to our overall growth. Selling, general and administrative expense, excluding the change in the deferred compensation plan, increased to 6.6% of consolidated revenues for the three months ended June 30, 2018 versus 6.5% in the corresponding period in 2017 .

Included in selling, general and administrative expense are gains and losses associated with changes in the value of investments under the deferred compensation plan. These investments represent the amounts held on behalf of the participating employees and changes in the value of these investments affect the amount of our deferred compensation liability. Gains on the plan investments during the three months ended June 30, 2018 and 2017 increased our total selling, general and administrative expense for these periods.

The table below summarizes the changes in these components of selling, general and administrative expense:
 
Three Months Ended June 30,
 
2018
 
2017
 
$ Change
 
% Change
 
(in thousands)
 
 
Selling, general and administrative expense excluding change in deferred compensation liability
$
33,231

 
$
30,840

 
$
2,391

 
7.8
 %
Gain on deferred compensation plan investments
887

 
1,151

 
(264
)
 
(22.9
)%
Selling, general and administrative expense
$
34,118

 
$
31,991

 
$
2,127

 
6.6
 %


Consolidated Investment and Interest Income, net

Investment and interest income decreased 12.9% for the three months ended June 30, 2018 compared to the corresponding 2017 period, primarily due to higher interest costs associated with our short-term borrowings. Partially offsetting these increased costs was higher interest received on our outstanding notes receivable.

Consolidated Income Taxes

During the three months ended June 30, 2018 , the Company recognized a provision for income taxes of  $7.5 million versus a provision for income taxes of $10.5 million for the same period in 2017 . On December 22, 2017, the U.S. enacted the Tax Cuts and Jobs Act, which lowered our U.S. statutory federal income tax rate from 35% to 21% effective January 1, 2018.

Our 2018 estimated annual effective tax rate is expected to be approximately 21% to 23% . The actual annual effective tax rate will be impacted by the tax effects of option exercises or vested awards, which are treated as discrete items in the reporting period in which they occur, and therefore cannot be considered in the calculation of the estimated annual effective tax rate. The income tax recognized from such discrete items for the three months ended June 30, 2018 was immaterial.


27



Table of Contents

Six Months Ended June 30, 2018 and 2017

The following table summarizes the income statement key components that we use to evaluate our financial performance on a consolidated and reportable segment basis, for the six months ended June 30, 2018 and 2017 . The differences between the reportable segments’ operating results and other disclosed data and our consolidated financial results relate primarily to corporate level transactions and adjustments related to transactions recorded at the reportable segment level which use methods other than generally accepted accounting principles.

 
Six Months Ended June 30,
 
2018
 
2017
 
% Change
 
(in thousands)
 
 
Revenues
 
 
 
 
 
Housekeeping
$
491,956

 
$
486,342

 
1.2
 %
Dietary
513,586

 
389,024

 
32.0
 %
Consolidated
$
1,005,542

 
$
875,366

 
14.9
 %
 
 
 
 
 
 
Costs of services provided
 
 
 
 
 
Housekeeping
$
433,941

 
$
441,666

 
(1.7
)%
Dietary
483,285

 
365,657

 
32.2
 %
Corporate and eliminations
(9,704
)
 
(54,431
)
 
(82.2
)%
Consolidated
$
907,522

 
$
752,892

 
20.5
 %
 
 
 
 
 
 
Selling, general and administrative expense
 
 
 
 
 
Corporate and eliminations
$
67,895

 
$
60,201

 
12.8
 %
 
 
 
 
 
 
Investment and interest income
 
 
 
 
 
Corporate and eliminations
$
1,796

 
$
3,084

 
(41.8
)%
 
 
 
 
 
 
Income (loss) before income taxes
 
 
 
 
 
Housekeeping
$
58,015

 
$
44,676

 
29.9
 %
Dietary
30,301

 
23,367

 
29.7
 %
Corporate and eliminations
(56,395
)
 
(2,686
)
 
1,999.6
 %
Consolidated
$
31,921

 
$
65,357

 
(51.2
)%

Housekeeping revenues represented 48.9% of consolidated revenues for the six months ended June 30, 2018 . Dietary revenues represented approximately 51.1% of consolidated revenues for the six months ended June 30, 2018 .

The following table sets forth the ratio which certain items bear to consolidated revenues:
 
Six Months Ended June 30,
 
2018
 
2017
Revenues
100.0
%
 
100.0
%
Operating costs and expenses:
 
 
 
Costs of services provided
90.3
%
 
86.0
%
Selling, general and administrative expense
6.8
%
 
6.9
%
Investment and interest income
0.2
%
 
0.4
%
Income before income taxes
3.1
%
 
7.5
%
Income taxes
0.6
%
 
2.4
%
Net income
2.5
%
 
5.1
%


28



Table of Contents

Revenues

Consolidated

Consolidated revenues increased 14.9% to $1.0 billion for the six months ended June 30, 2018 compared to $875.4 million for the corresponding period in 2017 as a result of the factors discussed below under Reportable Segments.

Reportable Segments

Housekeeping’s 1.2% net growth in reportable segment revenues resulted from service agreements entered into with new clients. Dietary’s 32.0% net growth in reportable segment revenues resulted primarily from providing these services to existing Housekeeping clients.

Costs of services provided

Consolidated

Consolidated costs of services increased 20.5% to $907.5 million for the six months ended June 30, 2018 compared to $752.9 million for the six months ended June 30, 2017 , which is primarily related to our 14.9% growth in consolidated revenues for the same period. As a percentage of consolidated revenues, costs of services increased to 90.3% in the six months ended June 30, 2018 from 86.0% in the corresponding period in 2017 .

Certain significant components within our costs of services provided are subject to fluctuation with changes in our business and client base. Labor and other labor-related costs, dining and housekeeping supplies, and self-insurance costs account for most of our consolidated costs of services provided. See the discussion under Reportable Segments below for additional information on the changes in the components of costs of services provided.

The following table provides a comparison of key indicators we consider when managing the consolidated costs of services provided:
 
 
Six Months Ended June 30,
Costs of Services Provided - Key Indicators as a % of Consolidated Revenue
 
2018
 
2017
 
Change
Bad debt provision
 
3.9%
 
0.2%
 
3.7%
Self-insurance costs
 
2.6%
 
2.7%
 
(0.1)%

The increase in the bad debt provision is related to the first quarter 2018 increase to the accounts receivable allowance, which was primarily related to the corporate restructuring of two privately-held multi-state operators.

Reportable Segments

Costs of services provided for Housekeeping, as a percentage of Housekeeping revenues, decreased to 88.2% for the six months ended June 30, 2018 from 90.8% in the corresponding period in 2017 . Costs of services provided for Dietary, as a percentage of Dietary revenues, increased to 94.1% for the six months ended June 30, 2018 from 94.0% in the corresponding period in 2017 .

The following table provides a comparison of the key indicators we consider when managing costs of services provided at the segment level, as a percentage of the respective segment’s revenues:
 
 
Six  Months Ended June 30,
Costs of Services Provided - Key Indicators as a % of Segment Revenue
 
201 8
 
201 7
 
Change
Housekeeping labor and other labor-related costs
 
78.3%
 
80.3%
 
(2.0)%
Housekeeping supplies
 
7.9%
 
8.1%
 
(0.2)%
Dietary labor and other labor-related costs
 
57.1%
 
54.6%
 
2.5%
Dietary supplies
 
34.9%
 
37.4%
 
(2.5)%

Variations within these key indicators relate to the provision of services at new facilities and changes in the mix of clients for whom we provide supplies or do not provide supplies. Management focuses on building efficiencies and managing labor and other costs at the facility level, as well as managing supply chain costs, for new and existing facilities.

29



Table of Contents


Selling, General and Administrative Expense

Excluding the change in the deferred compensation plan described below, consolidated selling, general and administrative expense increased $8.9 million or 15.4% during the six months ended June 30, 2018 compared to corresponding period in 2017 , related primarily to our overall growth. Selling, general and administrative expense, excluding the change in the deferred compensation plan, increased to 6.6% of consolidated revenues for the six months ended June 30, 2018 and in the corresponding period in 2017 .

Included in selling, general and administrative expense are gains and losses associated with changes in the value of investments under the deferred compensation plan. These investments represent the amounts held on behalf of the participating employees and changes in the value of these investments affect the amount of our deferred compensation liability. Gains on the plan investments during the six months ended June 30, 2018 and 2017 increased our total selling, general and administrative expense for these periods.

The table below summarizes the changes in these components of selling, general and administrative expense:
 
Six Months Ended June 30,
 
2018
 
2017
 
$ Change
 
% Change
 
(in thousands)
 
 
Selling, general and administrative expense excluding change in deferred compensation liability
$
66,777

 
$
57,888

 
$
8,889

 
15.4
 %
Gain on deferred compensation plan investments
1,118

 
2,313

 
(1,195
)
 
(51.7
)%
Selling, general and administrative expense
$
67,895

 
$
60,201

 
$
7,694

 
12.8
 %

Consolidated Investment and Interest Income, net

Investment and interest income decreased 41.8% for the six months ended June 30, 2018 compared to the corresponding 2017 period, primarily due to unfavorable market fluctuations in the value of our trading security investments representing the funding for our deferred compensation plan. Also contributing to the net decrease were higher interest costs associated with our short–term borrowings. Partially offsetting the net decrease was higher interest received on our outstanding notes receivable.

Consolidated Income Taxes

For the six months ended June 30, 2018 , the Company recognized a provision for income taxes of  $6.0 million versus a provision for income taxes of $20.8 million for the same period in 2017 . On December 22, 2017, the U.S. enacted the Tax Cuts and Jobs Act, which lowered our U.S. statutory federal income tax rate from 35% to 21% effective January 1, 2018.

The 2018 estimated annual effective tax rate is expected to be approximately 21% to 23% . The actual annual effective tax rate will be impacted by the tax effects of option exercises or vested awards, which are treated as discrete items in the reporting period in which they occur, and therefore cannot be considered in the calculation of the estimated annual effective tax rate. The impact of such discrete items was a $1.1 million income tax benefit for the six months ended June 30, 2018 .



30



Table of Contents

Liquidity and Capital Resources

Cash generated through operations is our primary source of liquidity. At June 30, 2018 , we had cash, cash equivalents and marketable securities of $88.1 million and working capital of $336.4 million , compared to December 31, 2017 cash, cash equivalents and marketable securities of $82.8 million and working capital of $343.2 million . The decrease in working capital was driven by a decrease in the Company’s net receivables, primarily as a result of the increase in the accounts receivable allowance as of June 30, 2018 compared with December 31, 2017 . As of June 30, 2018 , we had an unused line of credit of $193.6 million . Our current ratio was 3.0 to 1 at June 30, 2018 versus 2.9 to 1 at December 31, 2017 .

For the six months ended June 30, 2018 and 2017 , our cash flows were as follows:
 
Six Months Ended June 30,
 
2018
 
2017
 
(in thousands)
Net cash provided by (used in) operating activities
$
27,395

 
$
(6,561
)
Net cash used in investing activities
$
(6,028
)
 
$
(6,347
)
Net cash used in financing activities
$
(17,769
)
 
$
(3,887
)

Operating Activities

Our primary sources of cash from operating activities are the revenues generated from our Housekeeping and Dietary services. Our primary uses of cash from operating activities are the funding of our payroll and other personnel-related costs, as well as the costs of supplies used in providing our services. The timing of cash receipts and cash payments are the primary drivers of the period-over-period changes in net cash provided by operating activities.

Investing Activities

Our principal uses of cash for investing activities are the purchases of marketable securities and capital expenditures such as those for housekeeping and food service equipment, computer software and equipment, and furniture and fixtures (see “Capital Expenditures” below for additional information). Such uses of cash are partially offset by proceeds from sales of marketable securities.

Our investments in marketable securities are primarily comprised of tax-exempt municipal bonds and are intended to achieve our goal of preserving principal, maintaining adequate liquidity and maximizing returns subject to our investment guidelines. Our investment policy limits investment to certain types of instruments issued by institutions primarily with investment-grade ratings and places restrictions on concentration by type and issuer.

Financing Activities

The primary use of cash for financing activities is the payment of dividends. We have paid regular quarterly cash dividends since the second quarter of 2003. During 2018 , we paid regular quarterly cash dividends to shareholders totaling $28.4 million as follows:
 
Quarter Ended
 
March 31, 2018
 
June 30, 2018
 
(amounts in thousands, except per share data)
Cash dividend paid per common share
$
0.19125

 
$
0.19250

Total cash dividends paid
$
14,149

 
$
14,249

Record date
February 16, 2018

 
May 25, 2018

Payment date
March 23, 2018

 
June 29, 2018


The dividends paid to shareholders during the six months ended June 30, 2018 were funded by cash generated from operations. Our Board of Directors reviews our dividend policy on a quarterly basis. Although there can be no assurance that we will continue to pay dividends or regarding the amount of future dividend payments, we expect to continue to pay a regular quarterly cash dividend.

The primary source of cash from financing activities is the net borrowings under our bank line of credit. We borrow for general corporate purposes as needed throughout the year. The outstanding short-term borrowings balance as of June 30, 2018 relates to

31



Table of Contents

cash flow requirements due to the timing of cash receipts and cash payments. Another source of cash from financing activities are the proceeds from the exercise of stock options by employees and directors. In connection with the establishment of our dividend policy, we adopted a Dividend Reinvestment Plan in 2003.

We remain authorized to repurchase 1.7 million shares of our Common Stock pursuant to previous Board of Directors’ authorization. During the three and six months ended June 30, 2018 and 2017 , we repurchased our Common Stock as part of the dividend reinvestment related to treasury shares held within the Deferred Compensation Plan. The number of shares and value of shares repurchased were immaterial for both the three and six months ended June 30, 2018 and 2017 .

Line of Credit

At June 30, 2018 , we had a $300 million bank line of credit on which to draw for general corporate purposes. The amounts drawn under the line of credit are payable upon demand and generally bear interest at LIBOR plus 75 basis points. At June 30, 2018 , there were $40.5 million in borrowings under the line of credit. At June 30, 2018 , we also had outstanding $65.9 million in irrevocable standby letters of credit, which relate to payment obligations under our insurance programs. In connection with the issuance of the letters of credit, the amount available under the line of credit was reduced by $65.9 million to $193.6 million at June 30, 2018 .

The line of credit requires us to satisfy one financial covenant. The covenant and its respective status at June 30, 2018 was as follows:
Covenant Description and Requirement
 
As of June 30, 2018
Funded debt (1)  to EBITDA (2)  ratio: less than 3.00 to 1.00
 
0.96


(1)  
All indebtedness for borrowed money including, but not limited to, reimbursement obligations in respect of letters of credit and guaranties of any such indebtedness.
(2)  
Net income plus interest expense, income tax expense, depreciation, amortization.

As noted above, we were in compliance with our financial covenant at June 30, 2018 and we expect to remain in compliance. The line of credit expires on December 18, 2018 . Although no assurances can be provided that we will renew the line of credit or secure other financing, we expect the line of credit to be renewed prior to expiration, or substituted with another form of financing.

Accounts and Notes Receivable

Decisions to grant or to extend credit to customers are made on a case-by-case basis and based on a number of qualitative and quantitative factors related to the particular client as well as the general risks associated with operating within the healthcare industry.

Fluctuations in net accounts and notes receivable are attributable to a variety of factors including, but not limited to, the timing of cash receipts from customers, the Company’s assessment of collectability and corresponding provision for bad debt expense and the inception, transition or termination of client relationships.

We deploy significant resources and have invested in tools and processes to optimize our credit and collections efforts. When appropriate, we utilize interest-bearing promissory notes as an alternative to accounts receivable to further enhance the collectability of amounts due by memorializing the amount and related payment schedule as well as securing additional business protections and guarantees.


32



Table of Contents

Summarized below are the balances in our allowance for doubtful accounts, along with the provision for bad debts and net write-offs for each quarter of the six months ended June 30, 2018 . The change in our provision from during the first quarter of 2018 is primarily related to the corporate restructuring of two privately–held multi– state operators. The aggregate client account balances to which the reserve balances relate totaled $30.0 million , $98.2 million and $102.6 million as of December 31, 2017 , March 31, 2018 and June 30, 2018 , respectively.
 
Allowance for Doubtful Accounts
 
(in thousands)
Balance December 31, 2017
$
11,984

Provision for bad debts
37,137

Net write-offs of client accounts receivable
(216
)
Balance March 31, 2018
48,905

Provision for bad debts
2,250

Net write-offs of client accounts receivable
(1,446
)
Balance June 30, 2018
$
49,709


We evaluate our notes receivable for impairment quarterly and on an individual client basis. Notes receivable are generally evaluated for impairment when the respective clients are either in bankruptcy, are subject to collections activity or are slow payers that are experiencing financial difficulties. In the event that the evaluation results in a determination that a note receivable is impaired, it is valued at the present value of expected future cash flows or at the market value of related collateral. A summary schedule of impaired notes receivable, and the related reserve, for the six months ended June 30, 2018 is as follows:
 
Balance
December 31, 2017
 
Additions
 
Deductions
 
Balance
June 30, 2018
 
(in thousands)
Impaired Notes Receivable
$
6,854

 
$
582

 
$
(1,255
)
 
$
6,181

Reserve for Impaired Notes Receivable
$
2,884

 
$
2,233

 
$
(627
)
 
$
4,490


Capital Expenditures

The level of capital expenditures is generally dependent on the number of new clients obtained. Such capital expenditures primarily consist of housekeeping and food service equipment purchases, laundry and linen equipment installations, computer hardware and software, and furniture and fixtures. Although we have no specific material commitments for capital expenditures through the end of calendar year 2018 , we estimate that for 2018 we will have capital expenditures of approximately $4.5 million to $6.0 million . We believe that our cash from operations, existing cash and cash equivalents balance and credit line will be adequate for the foreseeable future to satisfy the needs of our operations and to fund our anticipated growth. However, should these sources not be sufficient, we would seek to obtain necessary capital from such sources as long-term debt or equity financing.

Material Off-Balance Sheet Arrangements

We have no material off-balance sheet arrangements, other than our irrevocable standby letter of credit previously discussed.


33



Table of Contents

Item 3.   Quantitative and Qualitative Disclosures About Market Risk

At June 30, 2018 , we had $88.1 million in cash, cash equivalents and marketable securities. The fair values of all of our cash equivalents and marketable securities are determined based on “Level 1” or “Level 2” inputs, which are based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. We place our cash investments in instruments that meet credit quality standards, as specified in our investment policy guidelines.

Investments in both fixed-rate and floating-rate investments carry a degree of interest rate risk. The market value of fixed rate securities may be adversely impacted by an increase in interest rates, while floating rate securities may produce less income than expected if interest rates fall. Due in part to these factors, our future investment income may fall short of expectations due to changes in interest rates or if there is a decline in the fair value of our investments.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are intended to ensure that information required to be disclosed in our reports under the Securities Exchange Act of 1934 (the “Exchange Act”), such as this Form 10-Q, is reported in accordance with Securities and Exchange Commission rules. Disclosure controls are also intended to ensure that such information is accumulated and communicated to Management, including the President and Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Based on their evaluation as of June 30, 2018 , pursuant to Exchange Act Rule 13a-15(b), our Management, including our President and Chief Executive Officer and Chief Financial Officer, believe our disclosure controls and procedures (as defined in Exchange Act 13a-15(e)) are effective.

Changes in Internal Controls over Financial Reporting

In connection with the evaluation pursuant to Exchange Act Rule 13a-15(d) of our internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f)) by our Management, including our President and Chief Executive Officer and Chief Financial Officer, no changes during the quarter ended June 30, 2018 were identified that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Certifications

Certifications of the Principal Executive Officer and Principal Financial and Accounting Officer regarding, among other items, disclosure controls and procedures are included as exhibits to this Form 10-Q.


34



Table of Contents

PART II — OTHER INFORMATION

Item 1. Legal Proceedings

In the normal course of business, the “Company is involved in various administrative and legal proceedings, including labor and employment, contracts, personal injury, and insurance matters. The Company believes it is not a party to, nor are any of its properties the subject of, any pending legal proceeding or governmental examination that would have a material adverse effect on the Company’s consolidated financial condition or liquidity. However, in light of the uncertainties involved in such proceedings, the ultimate outcome of a particular matter could become material to the Company’s results of operations for a particular period depending on, among other factors, the size of the loss or liability imposed and the level of the Company’s operating income for that period.

Item 1A. Risk Factors

There have been no material changes in the risk factors set forth in Part I, Item 1A, “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended  December 31, 2017 .

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Not applicable.

Item 3. Defaults Upon Senior Securities

Not applicable.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

Not applicable.

Item 6. Exhibits

The following exhibits are filed as part of this Report:
Exhibit Number
 
Description
10.1*
 
31.1
 
31.2
 
32.1
 
101
 
The following financial information from the Company’s Form 10-Q for the quarterly period ended June 30, 2018 formatted in eXtensible Business Reporting Language (XBRL): (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Comprehensive Income, (iii) Consolidated Statements of Cash Flows, (iv) Consolidated Statement of Stockholders’ Equity, and (v) Notes to Consolidated Financial Statements

* Indicates a management plan or compensation plan or arrangement.

35



Table of Contents

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant had duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


 
 
HEALTHCARE SERVICES GROUP, INC.
 
 
 
 
Date:
July 27, 2018
 
 /s/ Theodore Wahl
 
 
 
Theodore Wahl
 
 
 
President & Chief Executive Officer
 
 
 
(Principal Executive Officer)
 
 
 
 
Date:
July 27, 2018
 
 /s/ John C. Shea
 
 
 
John C. Shea
 
 
 
Chief Financial Officer
 
 
 
(Principal Financial and Accounting Officer)
 
 
 
 



36


SECOND AMENDED AND RESTATED
HEALTHCARE SERVICES GROUP, INC.
2012 EQUITY INCENTIVE PLAN
1. Purpose .
The Healthcare Services Group, Inc. 2012 Equity Incentive Plan (the “ Plan ”) is intended to provide an incentive to employees, non-employee directors and advisors of Healthcare Services Group, Inc., a Pennsylvania corporation (the “ Company ”), and its Subsidiaries to remain in the service of the Company and its Subsidiaries and to align their interest in the success of the Company with the interests of the Company’s stockholders. The Plan seeks to promote the highest level of performance by providing an economic interest in the long-term success of the Company.
2.      Definitions .
For purposes of the Plan, the following terms have the following meanings:
Affiliate ” means, with respect to any Person, any other Person directly or indirectly controlling, controlled by or under common control with, such Person. For purposes of this definition, “ control ” (including with correlative meanings, the terms “ controlling ,” “ controlled by ,” or “ under common control with ”), as used with respect to any Person, shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting securities or by contract or otherwise.
Agreement ” means an agreement between the Company and an Eligible Person providing for the grant of an Award hereunder.
Award ” means any Option, Stock Appreciation Right, Restricted Share, Bonus Stock, Stock Unit, Performance Share, or other incentive payable in cash or in shares of Common Stock as may be designated by the Committee from time to time under the Plan.
Beneficial Owner ” shall have the meaning set forth in Rule 13d-3 under the 1934 Act.
Beneficiary ” or “ Beneficiaries ” means the person(s) designated by a Participant or such Participant’s Permitted Transferee in writing to the Company to receive payments or other distributions or rights pursuant to the Plan upon the death of such Participant or such Participant’s Permitted Transferee. If no Beneficiary is so designated or if no Beneficiary is living at the time a payment, distribution, or right becomes payable or distributable pursuant to the Plan, such payment, distribution, or right shall be made to the estate of the Participant or a Permitted Transferee thereof. The Participant or Permitted Transferee, as the case may be, shall have the right to change the designated Beneficiaries from time to time by written instrument filed with the Committee in accordance with such rules as may be specified by the Committee.
Board of Directors ” means the Board of Directors of the Company.
Bonus Shares ” mean an Award of shares of Common Stock granted under Section 9 that are fully vested when granted.
Cashless Exercise ” means an exercise of Vested Options outstanding under the Plan through (a) the delivery of irrevocable instructions to a broker to make a sale of a number of Option Shares that results in proceeds thereon in an amount required to pay the aggregate exercise price for all the shares underlying such Vested Options being so exercised (and any required withholding tax) and to deliver such proceeds to the Company in satisfaction of such aggregate exercise price (and any required withholding tax) or (b) any other surrender to the Company of Option Shares or Vested Options outstanding under the Plan to satisfy the applicable aggregate exercise price (and any withholding tax) required to be paid upon such exercise.
Cause ” means, with respect to any Participant, (a) “cause” as defined in an employment agreement or any other similar type of agreement applicable to the Participant (so long as any act or omission constituting “cause” for such purpose was willful), or (b) in the case of a Participant who does not have an employment agreement or any other similar type of agreement or has an employment agreement or any other similar type of agreement that does not define “cause”: (i) any act or omission that constitutes a material breach by the Participant of any of such Participant’s obligations under such Participant’s employment agreement (if any) with the Company or any of its Subsidiaries, the applicable Agreement or any other agreement with the Company or any of its Subsidiaries; (ii) the willful and continued failure or refusal of the Participant substantially to perform the duties required of such Participant as an employee of the Company or any of its Subsidiaries, or performance significantly below the level required or expected of the Participant, as determined by the Committee; (iii) any willful violation by the Participant of any federal or state law or regulation applicable to the business of the Company or any of its Subsidiaries or Affiliates including, but not limited to, the rules and regulations promulgated by the Securities and Exchange Commission as well as the provisions of the Sarbanes-Oxley Act of 2002, the Dodd-Frank Wall Street Reform and Consumer Protection Act, or the Participant’s commission of any felony or other crime involving moral turpitude, or any willful perpetration by the Participant of a common law fraud; or (iv) any other misconduct by the Participant that is materially injurious to the financial condition or business reputation of, or is otherwise materially injurious to, the Company or any of its Subsidiaries or Affiliates.
Change in Control ” means the occurrence of any one of the following:
(a)      a tender offer (or series of related offers) shall be made and consummated for the ownership of 50% or more of the outstanding voting securities of the Company, unless as a result of such tender offer more than 50% of the outstanding voting securities of the surviving or resulting corporation shall be owned in the aggregate by the stockholders of the Company (as of the time immediately prior to the commencement of such offer), any employee benefit plan of the Company or its Subsidiaries, and their affiliates;
(b)      the Company shall be merged or consolidated with another corporation, unless as a result of such merger or consolidation more than 50% of the outstanding voting securities of the surviving or resulting corporation shall be owned in the aggregate by the stockholders of the Company (as of the time immediately prior to such transaction), any employee benefit plan of the Company or its Subsidiaries, and their affiliates;
(c)      the Company shall sell substantially all of its assets to another corporation that is not wholly owned by the Company, unless as a result of such sale more than 50% of such assets shall be owned in the aggregate by the stockholders of the Company (as of the time immediately prior to such transaction), any employee benefit plan of the Company or its Subsidiaries and their affiliates; or
(d)      a Person (as defined below) shall acquire 50% or more of the outstanding voting securities of the Company (whether directly, indirectly, beneficially or of record), unless as a result of such acquisition more than 50% of the outstanding voting securities of the surviving or resulting corporation shall be owned in the aggregate by the stockholders of the Company (as of the time immediately prior to the first acquisition of such securities by such Person), any employee benefit plan of the Company or its Subsidiaries, and their affiliates;
(e)      a majority of the members of the Board is replaced during any 12-month period by directors whose appointment or election is not endorsed by a majority of the members of the Board prior to the date of the appointment or election.
For purposes of this definition, ownership of voting securities shall take into account and shall include ownership as determined by applying the provisions of Rule 13d-3(d)(I)(i) (as in effect on the date hereof) under the 1934 Act. In addition, for such purposes, “Person” shall have the meaning given in Section 3(a)(9) of the 1934 Act, as modified and used in Sections 13(d) and 14(d) thereof, however, a Person shall not include (A) the Company or any of its Subsidiaries; (B) a trustee or other fiduciary holding securities under an employee benefit plan of the Company or any of its Subsidiaries; (C) an underwriter temporarily holding securities pursuant to an offering of such securities; or (D) a corporation owned, directly or indirectly, by the stockholders of the Company in substantially the same proportion as their ownership of stock of the Company.
Code ” means the Internal Revenue Code of 1986, as amended, including the rules and regulations promulgated thereunder.
Committee ” means a Committee of the Board of Directors appointed to administer the Plan.
Common Stock ” means shares of Common Stock, par value $0.01 per share, of the Company.
Competing Business ” means a business or enterprise (other than the Company and its direct or indirect Subsidiaries) that is engaged in the housekeeping, laundry, linen, and/or dietary services business, in any form whatsoever, which services healthcare and/or healthcare-related institutions in the continental United States or Canada.
Date of Grant ” means the date of grant of an Award as set forth in the applicable Agreement.
Delay Period ” shall have the meaning set forth in Section 24.
Effective Date ” shall have the meaning set forth in Section 25.
Eligible Persons ” means employees, non-employee directors and advisors of the Company and its Subsidiaries.
Fair Market Value ” means, with respect to a share of Common Stock on any relevant day, (a) if such Common Stock is traded on a national securities exchange, the closing price at the end of the applicable business day on such day, or if the Common Stock did not trade on such day, the closing price on the most recent preceding day on which there was a trade, (b) if such Common Stock is quoted on an automated quotation system, the closing price on such day, or if the Common Stock did not trade on such day, the mean between the closing bid and asked prices on such day, or (c) in all other cases, the “fair market value” as determined by the Committee in good faith and using such financial sources as it deems relevant and reliable (but in any event not less than fair market value within the meaning of Code Section 409A).
Good Reason ” means, with respect to any Participant, (a) “good reason” as defined in an employment agreement or any other similar type of agreement applicable to such Participant, or (b) in the case of a Participant who does not have an employment agreement or any other similar type of agreement that defines “good reason,” a failure by the Company to pay material compensation due and payable to the Participant in connection with such Participant’s employment.
Incentive Stock Option ” means an Option granted with the intention that it qualify as an “incentive stock option” as that term is defined in Code Section 422 or any successor provision.
1933 Act ” means the Securities Act of 1933, as amended, and the rules and regulations of the Commission thereunder.
1934 Act ” means the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission thereunder.
Nonqualified Stock Option ” means an Option other than an Incentive Stock Option.
Option ” means a right to purchase Common Stock granted pursuant to Section 8.
Option Price ” means, with respect to any Option, the exercise price per share of Common Stock to which it relates.
Option Shares ” means the shares of Common Stock acquired by a Participant upon exercise of an Option.
Outstanding ,” with respect to any share of Common Stock, means, as of any date of determination, all shares that have been issued on or prior to such date, other than shares repurchased or otherwise reacquired by the Company or any Affiliate thereof, on or prior to such date.
Participant ” means any Eligible Person who has been granted an Award.
Performance Share ” has the meaning set forth in Section 12.
Permanent Disability ,” with respect to any Participant who is an employee of the Company or any of its Subsidiaries, shall mean a permanent and total disability as defined in Code Section 22(e)(3).
Permitted Transferee ” means, (a) with respect to outstanding shares of Common Stock held by any Participant, any Person with respect to which the Board of Directors shall have adopted a resolution stating that the Board of Directors has no objection if a transfer of shares is made to such Person, and (b) with respect to Awards, or any other share of Common Stock issued as or pursuant to any Award, held by any Participant, (i) any Person to whom such Awards or other shares are transferred by will or the laws of descent and distribution or (ii) the Company.
Person ” means an individual, a partnership, a joint venture, a corporation, an association, a trust, an estate or other entity or organization, including a government or any department or agency thereof.
Qualifying Performance Criteria ” has the meaning set forth in Section 14(a) of the Plan.
Restricted Shares ” mean shares of Common Stock awarded to a Participant subject to the terms and conditions of the Plan under Section 9, the rights of ownership of which are subject to restrictions prescribed by the Committee.
Retirement ,” with respect to any Participant who is an employee of the Company or any of its Subsidiaries, means resignation or termination of employment (other than termination for Cause) upon the first to occur of the Participant’s attaining (a) age 62 or (b) age 55 with 20 years of service with the Company or a Subsidiary (including years of service granted by the Company or a Subsidiary as a result of a merger, acquisition, or other transaction); further provided that the Committee may determine in its sole discretion that a resignation or termination of employment under other circumstances shall be considered “Retirement” for purposes of the Plan.
Stock Appreciation Right ” means a right that entitles the Participant to receive, in cash or Common Stock (as determined by the Committee in its sole discretion) value equal to or otherwise based on the excess of (a) the Fair Market Value of a specified number of shares of Common Stock at the time of exercise over (b) the exercise price of the right, as established by the Committee on the Date of Grant.
Stock Unit ” means an Award granted under Section 11 denominated in units of Common Stock.
Subsidiary ” means any corporation in which more than 50% of the total combined voting power of all classes of stock is owned, either directly or indirectly, by the Company or another Subsidiary.
Substitute Award ” means any Award issued by the Company in connection with a merger (in which the Company is the survivor), acquisition or other corporate transaction.
Vested Options ” means, as of any date of determination, Options that by their terms have vested and are exercisable on such date.
Vested Restricted Shares ” means, as of any date of determination, Restricted Shares that by their terms have vested as of such date.
A “ Wrongful Solicitation ” shall be deemed to occur when a Participant or former Participant directly or indirectly (except in the course of such Participant’s employment with the Company), for the purpose of conducting or engaging in a Competing Business, calls upon, solicits, advises or otherwise does, or attempts to do, business with any Person who is, or was, during the then most recent 12-month period, a client of the Company or any of its Affiliates, or takes away or interferes or attempts to take away or interfere with any custom, trade, business, patronage or affairs of the Company or any of its Affiliates, or hires or attempts to hire any Person who is, or was during the most recent 12-month period, an employee, officer, representative or agent of the Company or any of its Affiliates, or solicits, induces, or attempts to solicit or induce any person who is an employee, officer, representative or agent of the Company or any of its Affiliates to leave the employ of the Company or any of its Affiliates, or violate the terms of their contract, or any employment agreement, with it.
3.      Administration of the Plan .
(a)      Members of the Committee . The Plan shall be administered, and Awards shall be granted hereunder, by the Committee.
(b)      Authority of the Committee . Subject to Section 3(a), the Committee shall have full discretionary power and authority, subject to such resolutions not inconsistent with the provisions of the Plan or applicable law as may from time to time be adopted by the Board, to (a) interpret and administer the Plan and any instrument or agreement entered into under the Plan, (b) establish such rules and regulations and appoint such agents as it shall deem appropriate for the proper administration of the Plan, and (c) make any determination and take any other action that the Committee deems necessary or desirable for administration of the Plan. All questions of interpretation, administration, and application of the Plan shall be determined in good faith by a majority of the members of the Committee then in office, except that the Committee may authorize any one or more of its members, or any officer of the Company, to execute and deliver documents on behalf of the Committee, and the determination of such majority shall be final and binding in all matters relating to the Plan.
4.      Number of Shares Issuable in Connection with Awards .
(a)      Limit . The initial total aggregate number of shares of Common Stock for which Awards may be made under the Plan shall not exceed 5% of the Company’s issued and outstanding Common Stock on the date of the approval of this Plan by the Company’s shareholders. Notwithstanding the foregoing, the number of shares of Common Stock available for issuance under the Plan, including shares subject to then outstanding Awards, shall automatically increase on the first trading day of January of each calendar year during the term of the Plan, beginning with calendar year 2013, by an amount equal to the lesser of (i) 5% of the positive difference, if any, between the number of outstanding shares of Common Stock, including shares subject to outstanding Awards, on the last trading day of the immediately preceding calendar year and the number of outstanding shares of Common Stock, including shares subject to outstanding Awards, on the first trading day of such immediately preceding calendar year; or (ii) an amount determined by the Board of Directors, in its discretion. No Incentive Stock Options may be granted on the basis of the additional shares of Common Stock resulting from such annual increases. The limitation established by this Section 4(a) shall be subject to adjustment as provided in Section 16. In addition, any shares that remain available for future grant in the Healthcare Services Group, Inc. 2002 Stock Option Plan (the “Prior Plan”) as of the Effective Date shall be added to the number of shares of Common Stock that may be issued under the Plan. Upon the Effective Date, no further awards may be made from the Prior Plan. Notwithstanding the foregoing, shares subject to a tandem SAR (as described more fully in Section 10 hereof) shall be charged against the authorized shares only once for the overall number of shares subject thereto and not for both the number of shares subject to the tandem SAR portion of the Award and the number of shares subject to the Option portion of the Award. The provisions of the preceding sentence shall apply whether an exercised tandem SAR is settled in cash or stock, or partly in both. Subject to the limitations contained in Section 8 hereof with respect to Incentive Stock Options, the maximum number of shares that may be granted as Stock Options or SARs under the Plan to an employee who is a Participant during any calendar year shall not exceed 50,000 shares.
(b)      Subject to the overall 5% limit, as adjusted, provided in Section 4(a), the maximum aggregate number of shares of Common Stock for which Restricted Shares may be awarded under the Plan shall not exceed 5% of the Company’s issued and outstanding Common Stock on the date of the approval of this Plan by the Company’s shareholders. The limitation established by the preceding sentence shall be subject to adjustment as provided in Section 4(a) above and Section 16.
(c)      If any Option is exercised by tendering Common Stock, either actually or by attestation, to the Company as full or partial payment in connection with the exercise of such Option under the Plan, or if the tax withholding requirements are satisfied through such tender, only the number of shares of Common Stock issued net of the Common Stock tendered shall be deemed delivered for purposes of determining the maximum number of shares available for Awards under the Plan.
(d)      Replenishment Provisions . Shares subject to any Awards that expire without being exercised or that are forfeited (and shares subject to awards made prior to the Effective Date under a Prior Plan that expire or are forfeited) shall again be available for future grants of Awards, provided that shares subject to a tandem SAR shall be replenished only once for the overall number of shares subject thereto and not for both the number of shares subject to the tandem SAR portion of the Award and the number of shares subject to the Option portion of the Award. Shares subject to Awards that have been retained by the Company in payment or satisfaction of the purchase price or tax withholding obligation of an Award shall not count against the limit set forth in paragraph (a) above. The Company shall not be under any obligation, however, to make any such future Awards.
(e)      Substitute Awards . Substitute Awards shall not count against the limitation set forth in paragraph (a) above.
(f)      Adjustments . The limits provided for in this Section 4 shall be subject to adjustment as provided in Section 16(a).
5.      Eligible Persons .
Awards may be granted or offered only to Eligible Persons. The Committee shall have the authority to select the individual Participants to whom Awards may be granted from among such class of Eligible Persons and to determine the number and form of Awards to be granted to each Participant.
6.      Agreement .
The terms and conditions of each grant or sale of Awards shall be embodied in an Agreement in a form approved by the Committee, which shall contain terms and conditions not inconsistent with the Plan and which shall incorporate the Plan by reference. Each Agreement shall: (a) state the date as of which the Award was granted or sold, and (i) in the case of Options and Stock Appreciation Rights, set forth the number of Options and Stock Appreciation Rights being granted to the Participant and the applicable Option Price and/or exercise price (for Stock Appreciation Rights) and expiration date(s), and (ii) in the case of Restricted Shares and other Awards, set forth the number of Restricted Shares or other Awards being granted or offered to the Participant and, if applicable, the purchase price or other consideration for such Restricted Shares or other Awards; (b) set forth the vesting schedule (if any); (c) set forth any other terms and conditions established by the Committee including any additional covenants and promises that the Committee deems, in its discretion, are necessary or desirable, which covenants and promises may include, but are not limited to, covenants regarding confidential information and trade secrets, covenants regarding company property, covenants not to compete, covenants not to solicit clients or accounts, cross‑over employment covenants, and covenants not to disparage the Company; (d) set forth any Qualifying Performance Criteria as the Committee may determine in its discretion; (e) be signed by the recipient of the Award and a person designated by the Committee; and (f) be delivered to the recipient of the Award.
7.      Restrictions on Transfer .
(a)      Restrictions on Transfer . No Restricted Share, Bonus Stock, Performance Share, or Option Share or other share of Common Stock issued as or pursuant to any Award may be sold, transferred, assigned, pledged, or otherwise encumbered or disposed of (or made the subject of any derivative transaction) to or with any third party (other than a Permitted Transferee); provided, however, that any such restriction on transfer shall terminate as to any such share when such share is no longer subject to any term, condition or other restriction under the Plan (other than Section 7(b)). No Option, Stock Appreciation Right, Stock Unit, or other Award not in the form of a share of Common Stock may be sold, transferred, assigned, pledged, or otherwise encumbered or disposed of (or made the subject of any derivative transaction) to or with any third party other than a Permitted Transferee. Each Permitted Transferee (other than the Company) by will or the laws of descent and distribution or otherwise, of any Award (or share issued in respect thereof) shall, as a condition to the transfer thereof to such Permitted Transferee, execute an agreement pursuant to which it shall become a party to the Agreement applicable to the transferor.
(b)      No Participant will, directly or indirectly, offer, sell, assign, transfer, grant or sell a participation in, create any encumbrance on or otherwise dispose of any Award or any Shares with respect thereto (or solicit any offers to buy or otherwise acquire, or take a pledge of, any Award or any Shares with respect thereto), in any manner that would conflict with or violate the 1933 Act.
8.      Options .
(a)      Terms of Options Generally . The Committee may grant Options designated as Incentive Stock Options or Nonqualified Stock Options. Options may be granted to any Eligible Person. Each Option shall entitle the Participant to whom such Option was granted to purchase, upon payment of the relevant Option Price, one share of Common Stock. Options granted under the Plan shall comply with the following terms and conditions:
(i)      Option Price .
A.      The Option Price for shares purchased under an Option shall be as determined by the Committee, but shall not be less than the Fair Market Value of the Common Stock as of the Date of Grant, except in the case of substitute awards issued by the Company in connection with an acquisition or other corporate transaction.
B.      The Option Price for shares purchased under an Option shall be paid in full to the Company by delivery of consideration equal to the product of the Option Price and the number of shares purchased, together with any amounts required to be withheld for tax purposes under Section 17(c) of this Plan. Such consideration must be paid before the Company will issue the shares being purchased and must be in a form or a combination of forms acceptable to the Committee for that purchase, which forms may (but are not required to) include:
(1)      cash;
(2)      check or wire transfer;
(3)      tendering (either actually or by attestation) shares of Common Stock already owned by the Participant, provided that the shares have been held for the minimum period required by applicable financial accounting rules to avoid a charge to the Company’s earnings for financial reporting purposes;
(4)      to the extent permitted by applicable law, Cashless Exercise; or
(5)      such other consideration as the Committee may permit in its sole discretion; provided, however, that any Participant may, at any time, exercise any Vested Option (or portion thereof) owned by such Participant pursuant to a Cashless Exercise without any prior approval or consent of the Committee.
(ii)      Vesting of Options . Each Option shall vest and become exercisable on such terms and conditions as shall be prescribed by the Committee in the applicable Award Agreement.
(iii)      Duration of Options . Subject to earlier termination in accordance with the terms of the Plan and the instrument evidencing the Option, the maximum term of an Option shall be as established for that Option by the Committee but in no event shall be greater than ten years from the Date of Grant.
(iv)      Exercise Following Termination of Employment . Except as may be provided in subsection (viii)(D) hereof, and unless otherwise determined by the Committee in its sole discretion, upon termination of a Participant’s employment with the Company and its Subsidiaries, the following terms and conditions shall apply:
A.      if the Participant’s employment is terminated by the Company other than for Cause, or as a result of the Participant’s resignation for Good Reason, or as a result of death, Permanent Disability or Retirement, the Participant (or, in the case of the Participant’s death, such Participant’s Beneficiary) may exercise any Options, to the extent vested as of the date of such termination, at any time until the earlier of (I) three months following the date of such termination of employment other than for Cause, or as a result of the Participant’s resignation for Good Reason; (II) 12 months following the date of such termination of employment due to Permanent Disability or death; (III) three years (three months for an Incentive Stock Option) following the date of such termination of employment due to Retirement; and (IV) the expiration of the Option under the provisions of clause (iii) above; and
B.      if the Participant’s employment is terminated by the Company for Cause, or as a result of the Participant’s resignation other than for Good Reason or Retirement, all of the Participant’s Options (whether or not vested) shall expire and be canceled without any payment therefor as of the date of such termination.
Any Options not exercised within the applicable time period specified above shall expire at the end of such period and be canceled without any payment therefor.
With respect to a non-employee director or advisor who is a Participant in the Plan, the references to termination of employment above shall be deemed to refer to termination of service as a director or termination of service as an advisor, as applicable, and as determined in the discretion of the Committee.
(v)      Certain Restrictions . Options granted hereunder shall be exercisable during the Participant’s lifetime only by the Participant.
(vi)      Stockholder Rights; Option and Share Adjustments . A Participant shall have no rights as a stockholder with respect to any shares of Common Stock issuable upon exercise of an Option until a certificate or certificates evidencing such shares shall have been issued to such Participant. Except as otherwise provided by the Board of Directors, no adjustment (including an adjustment of an Option’s exercise price) shall be made with respect to (A) outstanding Options for dividends or other distributions, whether made with respect to Common Stock or otherwise, or (B) dividends, distributions or other rights in respect of any share of Common Stock for which the record date is prior to the date upon which the Participant shall become the holder of record thereof.
(vii)      Dividends and Distributions . Any shares of Common Stock or other securities of the Company received by the Participant as a result of a stock dividend or other distribution in respect of Option Shares shall be subject to the same restrictions as such Option Shares.
(viii)      Incentive Stock Options . Incentive Stock Options granted under this Plan shall be subject to the following additional conditions, limitations, and restrictions:
A.      Incentive Stock Options may be granted only to employees of the Company or a Subsidiary or parent corporation of the Company, within the meaning of Code Section 424.
B.      No Incentive Stock Option may be granted under this Plan after the 10‑year anniversary of the date on which the Plan is adopted by the Board or, if earlier, the date on which the Plan is approved by the Company’s stockholders.
C.      The aggregate Fair Market Value (as of the Date of Grant) of the Common Stock with respect to which the Incentive Stock Options awarded to any Participant first become exercisable during any calendar year may not exceed $100,000. For purposes of the $100,000 limit, the Participant’s Incentive Stock Options under this Plan and all other plans maintained by the Company and its Subsidiaries will be aggregated. To the extent any Incentive Stock Option would exceed the $100,000 limit, the Incentive Stock Option will thereafter be treated as a Nonqualified Stock Option for all purposes. No Incentive Stock Option may be granted to any individual who owns stock possessing more than 10% of the total combined voting power of all classes of stock of the Company or any Subsidiary.
D.      If the Committee exercises its discretion to permit an Incentive Stock Option to be exercised by a Participant more than three months after the termination of a Participant’s employment for any reason or more than 12 months if the Participant is Permanently Disabled, the Incentive Stock Option will thereafter be treated as a Nonqualified Stock Option for all purposes. For purposes of this subclause D, a Participant’s employment relationship will be treated as continuing uninterrupted during any period that the Participant is on military leave, sick leave or another Approved Leave of Absence if the period of leave does not exceed 90 consecutive days, or a longer period to the extent that the Participant’s right to reemployment with the Company or a Subsidiary is guaranteed by statute or by contract. If the period of leave exceeds 90 consecutive days and the Participant’s right to reemployment is not guaranteed by statute or contract, the employment relationship will be deemed to have ceased on the 91st day of the leave.
(ix)      Additional Terms and Conditions . Each Option granted hereunder, and any shares of Common Stock issued in connection with such Option, shall be subject to such additional terms and conditions not inconsistent with the Plan as are prescribed by the Committee and set forth in the applicable Agreement.
(b)      Unvested Options . Unless otherwise determined by the Committee in its sole discretion, upon termination of a Participant’s employment or service with the Company and its Subsidiaries, all Options granted to such Participant that have not theretofore vested (and which do not vest by reason of such termination of employment or service) shall terminate and be canceled without any payment therefor.
9.      Restricted Shares and Bonus Shares .
(a)      Terms of Restricted Shares and Bonus Shares Generally . Restricted Shares and Bonus Shares awarded by the Committee shall not require payment of any consideration by Participants, except as otherwise determined by the Committee in its sole discretion.
(b)      Restricted Shares and Bonus Shares shall comply with the following terms and conditions:
(i)      Vesting . Any Awards of Restricted Shares shall vest in accordance with a vesting schedule to be specified by the Committee. Except (A) with respect to grants to the Company’s non-employee directors, or (B) as vesting may be accelerated pursuant to the terms of the Plan, such restrictions shall not fully terminate prior to three years after the Date of Grant. Bonus Shares shall be fully vested when granted.
(ii)      Stockholder Rights . Unless otherwise determined by the Committee in its sole discretion, a Participant shall have all rights of a stockholder as to the Restricted Shares and Bonus Shares awarded to such Participant, including the right to receive dividends and the right to vote in accordance with the Company’s Certificate of Incorporation, subject to the restrictions set forth in the Plan and the applicable Agreement.
(iii)      Dividends and Distributions . Any shares of Common Stock or other securities of the Company received by a Participant as a result of a stock distribution to holders of Restricted Shares or as a stock dividend on Restricted Shares shall be subject to the same restrictions as such Restricted Shares or Bonus Shares and all references to Restricted Shares or Bonus Shares hereunder shall be deemed to include such shares of Common Stock or other securities.
(iv)      Additional Terms and Conditions . Each Restricted Share and Bonus Share granted or offered for sale hereunder shall be subject to such additional terms and conditions not inconsistent with the Plan as are prescribed by the Committee and set forth in the applicable Agreement.
(c)      Unvested Restricted Shares . Unless otherwise determined by the Committee in its sole discretion, upon termination of a Participant’s employment or service with the Company and its Subsidiaries, all Restricted Shares granted or sold to such Participant that have not theretofore vested (and that do not vest by reason of such termination of employment) shall terminate and be canceled without any payment therefor.
10.      Stock Appreciation Rights .
Stock Appreciation Rights may be granted to Participants either alone (“ freestanding ”) or in addition to or in tandem with other Awards granted under the Plan and may, but need not, relate to a specific Option granted hereunder. The provisions of Stock Appreciation Rights need not be the same with respect to each grant or each recipient. Any Stock Appreciation Right granted in tandem with an Option may be granted at the same time such Option is granted or at any time thereafter before exercise or expiration of such Option. All Stock Appreciation Rights granted under the Plan shall be granted subject to the same terms and conditions applicable to Nonqualified Stock Options as set forth in Section 8(a); provided, however, that Stock Appreciation Rights granted in tandem with a previously granted Option shall have the same terms and conditions as such Option. Subject to the provisions of Section 8, the Committee may impose such other conditions or restrictions on any Stock Appreciation Right as it shall deem appropriate. Stock Appreciation Rights may be settled in Common Stock or cash as determined by the Committee in its sole discretion.
11.      Stock Units .
The Committee may also grant Awards of Stock Units under the Plan. With respect to each grant of Stock Units, the Committee shall determine in its sole discretion the period or periods, including any conditions for determining such period or periods, during which any restrictions on full vesting shall apply, provided that in no event, other than in connection with a termination of employment, or with respect to grants to non-employee directors, shall such period or periods be less than three years (the “ Unit Restriction Period ”). The Committee may also make any Award of Stock Units subject to the satisfaction of other conditions, including the attainment of performance goals, or contingencies (“ Unit Vesting Condition ”), in order for a Participant to receive payment of such Stock Unit Award, which shall be established by the Committee at the Date of Grant thereof. Awards of Stock Units shall be payable in Common Stock or cash as determined by the Committee in its sole discretion. The Committee may permit a Participant to elect to defer receipt of payment of all or part of any Award of Stock Units pursuant to rules and regulations adopted by the Committee. Unless the Committee provides otherwise at the Date of Grant of an Award of Stock Units, the provisions of Section 9 of this Plan relating to the vesting of Restricted Shares shall apply during the Unit Restriction Period or prior to the satisfaction of any Unit Vesting Condition for such Award.
12.      Performance Shares .
The Committee may grant Awards of Performance Shares and designate the Participants to whom Performance Shares are to be awarded and determine the number of Performance Shares, the length of the performance period and the other terms and conditions of each such Award. Each Award of Performance Shares shall entitle the Participant to a payment in the form of shares of Common Stock upon the attainment of performance goals (which may be Qualifying Performance Criteria) and other terms and conditions specified by the Committee. Notwithstanding satisfaction of any performance goals, the number of shares issued under an Award of Performance Shares may be adjusted on the basis of such further considerations as the Committee shall determine, in its sole discretion. However, the Committee may not, in any event, increase the number of shares earned upon satisfaction of any performance goal by any Participant subject to Code Section 162(m) to the extent such Section is applicable. The Committee, in its sole discretion, may make a cash payment equal to the Fair Market Value of the Common Stock otherwise required to be issued to a Participant pursuant to an Award of Performance Shares.
13.      Other Stock-Based Awards .
In addition to the Awards described in Sections 8 through 12, and subject to the terms of the Plan, the Committee may grant other Awards payable in shares of Common Stock under the Plan as it determines to be in the best interests of the Company and subject to such other terms and conditions as it deems appropriate.
14.      Performance‑Based Awards .
(a)      Qualifying Performance Criteria . Awards of Options, Restricted Shares, Stock Units, Performance Shares, and other Awards made pursuant to the Plan may be made subject to the attainment of performance goals relating to one or more business criteria. For purposes of the Plan, such business criteria shall mean any one or more of the following performance criteria, either individually, alternatively or in any combination: (a) cash flow; (b) earnings (including, without limitation, gross margin, earnings before interest and taxes, earnings before taxes, earnings before interest, taxes, depreciation and amortization, and net earnings); (c) earnings per share; (d) growth in earnings or earnings per share; (e) stock price; (f) return on equity or average stockholders’ equity; (g) total stockholder return; (h) return on capital; (i) return on assets or net assets; (j) return on investment; (k) sales, growth in sales or return on sales; (l) income or net income; (m) operating income or net operating income; (n) operating profit or net operating profit; (o) operating margin; (p) return on operating revenue; (q) economic profit, (r) market share; (s) overhead or other expense reduction; (t) growth in stockholder value relative to various stock indices, (u) strategic plan development and implementation, (v) net debt, (w) working capital (including components thereof), and (x) during the “reliance period” (as defined in Treasury Regulation section 1.162-27(f)(2)), any other similar objective financial performance metric selected by the Committee in its sole discretion (collectively, the “ Qualifying Performance Criteria ”). To the extent required by or consistent with Code Section 162(m), the Committee may appropriately adjust any evaluation of performance under a Qualifying Performance Criteria to exclude any of the following events that occur during a performance period: (z) asset write-downs or write-ups, (aa) litigation, claims, judgments or settlements, (bb) the effect of changes in tax law, accounting principles or other such laws or provisions affecting reported results, (cc) accruals for reorganization and restructuring programs, and (dd) any extraordinary, unusual or non-recurring items as described in Accounting Standards Codification (ASC) 225 and/or in management’s discussion and analysis of financial condition and results of operations appearing in the Company’s Annual Report to stockholders for the applicable year.
(b)      Any Qualifying Performance Criteria may be used to measure the performance of the Company as a whole or with respect to any business unit, subsidiary or business segment of the Company, either individually, alternatively or in any combination, and may be measured either annually or cumulatively over a period of years, on an absolute basis or relative to a pre‑established target, to previous period results or to a designated comparison group, in each case as specified by the Committee in the Award. To the extent required by Code Section 162(m), prior to the payment of any compensation under an Award intended to qualify as “performance-based compensation” under Code Section 162(m), the Committee shall certify the extent to which any such Qualifying Performance Criteria and any other material terms under such Award have been satisfied (other than in cases where such relate solely to the increase in the value of the Common Stock). To the extent Code Section 162(m) is applicable, the Committee may not in any event increase the amount of compensation payable to a Participant subject to Code Section 162(m) upon the satisfaction of any Qualifying Performance Criteria.
(c)      To the extent an Award is intended to qualify under Code Section 162(m), any language in the Award Agreement, Committee resolutions, or other agreements and actions in connection with the Award, to the extent inconsistent with Section 162(m) shall be deemed interpreted and modified to the minimum extent necessary so that such Awards are compliant with Code Section 162(m).
15.      Certain Forfeitures .
In the event (A) the Participant’s employment is terminated by the Company for Cause or (B) a Participant or former Participant engages in a Competing Business or in Wrongful Solicitation while in the employ of the Company or a Subsidiary, or during the period of 13 months immediately following termination of such employment, the following rules shall apply:
(a)      all Awards then held by the Participant (whether vested or not) shall be forthwith forfeited without payment or other compensation of any kind; provided, however, that the Company shall remit to the Participant the lesser of (i) the amount (if any) such Participant paid for forfeited Awards and (ii) in the case of Restricted Shares or Performance Shares, the Fair Market Value of such Restricted Shares as of the date of termination;
(b)      notwithstanding subclause (a), in the event Vested Restricted Shares or vested Performance Shares were disposed of (for or without receipt of value) during the period commencing one year prior to the initial engagement in a Competing Business or in Wrongful Solicitation through the 13-month anniversary of the Participant’s termination of employment with the Company or a Subsidiary, then, upon written demand by the Company, the Participant or former Participant, as the case may be, shall forthwith remit to the Company the Fair Market Value of such Vested Restricted Shares or vested Performance Shares, as determined on the date of disposition, less the amount (if any) paid by the Participant for such shares; and
(c)      in the event Option Shares, Shares obtained pursuant to the exercise of a Stock Appreciation Right or other Shares obtained pursuant to Awards under the Plan (and not described in subparagraph (b)) were disposed of (for or without receipt of value) during the period commencing one year prior to the initial engagement in a Competing Business or in Wrongful Solicitation through the 13-month anniversary of the Participant’s termination of employment with the Company or a Subsidiary, then, upon written demand by the Company, the Participant or former Participant, as the case may be, shall forthwith remit to the Company the Fair Market Value of such Shares, as determined on the date of disposition, less the Option Price or other amount (if any) paid therefor.
16.      Effect of Certain Corporate Changes and Changes in Control .
(a)      Dilution and Other Adjustments . If the Outstanding shares of Common Stock or other securities of the Company, or both, for which the Award is then exercisable or as to which the Award is to be settled shall at any time be changed or exchanged by declaration of a stock dividend, stock split, combination of shares, extraordinary dividend of cash and/or assets, recapitalization, or reorganization, the Committee may, and if such event occurs after a Change in Control, the Committee shall, appropriately and equitably adjust the number and kind of shares of Common Stock or other securities that are subject to the Plan or subject to any Awards theretofore granted, and the exercise or settlement prices of such Awards, so as to maintain the proportionate number of shares of Common Stock or other securities without changing the aggregate exercise or settlement price.
(b)      Change in Control . In the event of a Change in Control,
(i)      any outstanding Award shall, upon the occurrence of such Change in Control, be assumed and continued or an equivalent award substituted by the Company’s successor or a parent or subsidiary of such successor; provided, however that if a Participant, within two years after a Change in Control, terminates employment for Good Reason, or is terminated by the Company without Cause, Awards not previously vested shall immediately become vested, and
(ii)      provided, however, in the event that, upon the occurrence of such Change in Control, such outstanding Awards are not assumed and continued or an equivalent award is not substituted by the Company's successor or a parent or subsidiary of such successor, then
A.      such Awards not previously vested shall immediately become vested; and
B.      any vested and outstanding Award shall, upon the occurrence of such Change in Control, be cancelled in exchange for a payment in cash, stock or other consideration paid to shareholders with respect to such Change in Control, in an amount based on the Fair Market Value of the shares of Common Stock subject to the Award, less any Option Price, which amount may be zero if applicable, as the case may be.
17.      Miscellaneous .
(a)      No Rights to Grants or Continued Employment or Engagement . No Participant shall have any claim or right to receive grants of Awards under the Plan. Neither the Plan nor any action taken or omitted to be taken hereunder shall be deemed to create or confer on any Participant any right to be retained in the employ or as a director of the Company or any Subsidiary or other Affiliate thereof, or to interfere with or to limit in any way the right of the Company or any Subsidiary or other Affiliate thereof to terminate the employment or other retention of such Participant at any time.
(b)      Right of Company to Assign Rights and Delegate Duties . The Company shall have the right to assign any of its rights and delegate any of its duties hereunder to any of its Affiliates. The terms and conditions of any Award under the Plan shall be binding upon and shall inure to the benefit of the personal representatives, heirs, legatees, and permitted successors and assigns of the relevant Participant and the Company.
(c)      Tax Withholding . The Company and its Subsidiaries may require the Participant to pay to the Company the amount of any taxes that the Company is required by applicable federal, state, local or other law to withhold with respect to the grant, vesting, or exercise of an Award. The Company shall not be required to issue any shares of Common Stock under the Plan until such obligations are satisfied in full. The Committee may in its sole discretion permit or require a Participant to satisfy all or part of such Participant’s tax withholding obligations by (1) paying cash to the Company, (2) having the Company withhold a number of shares of Common Stock that would otherwise be issued to the Participant (or become vested in the case of Restricted Shares), having a Fair Market Value equal to the tax withholding obligations, (3) surrendering a number of shares of Common Stock the Participant already owns, having a Fair Market Value equal to the tax withholding obligations, or (4) entering into such other arrangement as is acceptable to the Committee in its sole discretion. The value of any shares withheld or surrendered may not exceed the employer’s minimum tax withholding obligation and, to the extent such shares were acquired by the Participant from the Company as compensation, the shares must have been held for the minimum period required by applicable accounting rules to avoid a charge to the Company’s earnings for financial reporting purposes. The Company and its Subsidiaries shall also have the right to deduct from any and all cash payments otherwise owed to a Participant any federal, state, local or other taxes required to be withheld with respect to the Participant’s participation in the Plan.
(d)      No Restriction on Right of Company to Effect Corporate Changes . The Plan shall not affect in any way the right or power of the Company or its stockholders to make or authorize any or all adjustments, recapitalizations, reorganizations or other changes in the Company’s capital structure or its business, or any merger or consolidation of the Company, or any issue of stock or of options, warrants or rights to purchase stock or of bonds, debentures, preferred or prior preference stocks whose rights are superior to or affect the Common Stock or the rights thereof or that are convertible into or exchangeable for Common Stock, or the dissolution or liquidation of the Company, or any sale or transfer of all or any part of its assets or business, or any other corporate act or proceeding, whether of a similar character or otherwise.
(e)      1934 Act . Notwithstanding anything contained in the Plan or any Agreement to the contrary, if the consummation of any transaction under the Plan would result in the possible imposition of liability on a Participant pursuant to Section 16(b) of the 1934 Act, the Committee shall have the right, in its sole discretion, but shall not be obligated, to defer such transaction to the extent necessary to avoid such liability.
(f)      Securities Laws . Notwithstanding any other provision of the Plan, the Company shall have no obligation to issue or deliver any shares of Common Stock under the Plan or make any other distribution of benefits under the Plan unless, in the judgment of the Committee, such issuance, delivery or distribution would comply with all applicable laws (including, without limitation, the requirements of the 1933 Act and 1934 Act or the laws of any state or foreign jurisdiction) and the applicable requirements of any securities exchange or similar entity.
(g)      Severability . If any provision of the Plan or any Award is determined to be invalid, illegal or unenforceable in any jurisdiction, or as to any Person, or would disqualify the Plan or any Award under any law deemed applicable by the Committee, such provision shall be construed or deemed amended to conform to applicable laws, or, if it cannot be so construed or deemed amended without, in the Committee’s determination, materially altering the intent of the Plan or the Award, such provision shall be stricken as to such jurisdiction, person or Award, and the remainder of the Plan and any such Award shall remain in full force and effect.
(h)      Vesting .
(i)      Notwithstanding anything to the contrary contained in the Plan, a minimum period over which full-value, performance-based awards and full-value, tenure-based awards granted under the Plan may entirely vest shall be set forth in each Agreement, respectively; provided, however, that up to 10% of the shares authorized under the Plan shall not be subject to such restrictions; and, provided, further, that such restrictions shall not affect or otherwise limit any acceleration of vesting pursuant to the Plan or set forth in the applicable Agreement.
(ii)      Notwithstanding anything to the contrary contained in the Plan, but subject to Section 15, unless otherwise provided in an applicable Agreement, in the event of a Participant’s termination of employment or service by reason of Retirement, Permanent Disability or death, such Participant’s then unvested awards shall automatically become vested, and in the case of Options or SARs, exercisable.
18.      Amendment .
The Board of Directors may at any time and from time to time alter, amend, suspend, or terminate the Plan in whole or in part. No termination or amendment of the Plan may, without the consent of the Participant to whom any Awards shall previously have been granted, adversely affect the rights of such Participant in such Awards. In addition, no amendment of the Plan shall, without the approval of the stockholders of the Company:
(a)      change the class of individuals eligible for awards under the Plan;
(b)      increase the maximum number of shares of Common Stock for which Awards may be granted under this Plan;
(c)      reduce the price at which Options may be granted below the price provided for in Section 8(a) hereof;
(d)      reduce the Option Price of outstanding Options;
(e)      cancel an Option or Stock Appreciation Right in exchange for cash when the exercise or grant price per share exceeds the Fair Market Value of one share of Common Stock or take any action with respect to an Option or Stock Appreciation Right that would be treated as a repricing under the rules and regulations of the principal securities exchange on which the Common Stock is traded; or
(f)      extend the term of this Plan.
19.      Termination of the Plan .
The Plan shall continue until terminated by the Board of Directors pursuant to Section 18 or as otherwise set forth in this Plan, and no further Awards shall be made hereunder after the date of such termination. Unless earlier terminated, the Plan shall terminate ten (10) years after the Effective Date (provided the awards granted before that date shall continue in accordance with their terms).
20.      Conditions to Issuance of Shares .
(a)      The Company shall be under no obligation to any Participant to register for offering or resale or to qualify for exemption under the 1933 Act, or to register or qualify under the laws of any state or foreign jurisdiction, any shares of Common Stock, security or interest in a security paid or issued under, or created by, the Plan, or to continue in effect any such registrations or qualifications if made. The Company may issue certificates for shares with such legends and subject to such restrictions on transfer and stop-transfer instructions as the Committee deems necessary or desirable for compliance by the Company with federal, state, and foreign securities laws. The Company may also require such other action or agreement by the Participants as may from time to time be necessary to comply with applicable securities laws.
(b)      To the extent the Plan or any instrument evidencing an Award provides for issuance of stock certificates to reflect the issuance of shares of Common Stock, the issuance may be effected on a noncertificated basis, to the extent not prohibited by applicable law or the applicable rules of any stock exchange.
21.      Headings; Number; Gender .
The headings of sections and subsections herein are included solely for convenience of reference and shall not affect the meaning of any of the provisions of the Plan.
Words used herein in the singular form shall be construed as being used in the plural form, as appropriate in the relevant context, and vice versa. Pronouns used herein of one gender shall be construed as referring to either or both genders, as appropriate in the relevant context.
22.      Limited Waiver .
The waiver by the Company of any of its rights under the Plan with respect to any Participant, whether express or implied, shall not operate or be construed as a waiver of any other rights the Company has with respect to such Participant or of any of its rights with respect to any other Participant.
23.      Governing Law .
The Plan and all rights hereunder shall be governed by and construed in accordance with the laws of the Commonwealth of Pennsylvania without reference to rules relating to conflicts of law.
24.      Compliance with Code Section 409A .
(a)      This Plan is intended to comply and shall be administered in a manner that is intended to comply with Code Section 409A and shall be construed and interpreted in accordance with such intent. To the extent that an Award or the payment, settlement, or deferral thereof is subject to Code Section 409A, the Award shall be granted, paid, settled, or deferred in a manner that will comply with Code Section 409A, including regulations or other guidance issued with respect thereto, except as otherwise determined by the Committee. Any provision of this Plan that would cause the grant of an Award or the payment, settlement, or deferral thereof to fail to satisfy Code Section 409A shall be amended to comply with Code Section 409A on a timely basis, which may be made on a retroactive basis, in accordance with regulations and other guidance issued under Code Section 409A.
(b)      Notwithstanding anything in the Plan to the contrary, the receipt of any benefits under this Plan, subject to Code Section 409A as a result of a termination of employment, shall be subject to satisfaction of the condition precedent that the Participant undergo a “separation from service” within the meaning of Treas. Reg. § 1.409A-1(h) or any successor thereto. In addition, if a Participant is deemed to be a “specified employee” within the meaning of that term under Code Section 409A(a)(2)(B), then with regard to any payment or the provisions of any benefit that is required to be delayed pursuant to Code Section 409A(a)(2)(B), such payment or benefit shall not be made or provided prior to the earlier of (i) the expiration of the six month period measured from the date of the Participant's “separation from service” (as such term is defined in Treas. Reg. § 1.409A-1(h)), or (ii) the date of the Participant's death (the “ Delay Period ”). Within ten (10) days following the expiration of the Delay Period, all payments and benefits delayed pursuant to this Section (whether they would have otherwise been payable in a single sum or in installments in the absence of such delay) shall be paid or reimbursed to the Participant in a lump sum, and any remaining payments and benefits due under this Plan shall be paid or provided in accordance with the normal payment dates specified for them herein.
25.      Effective Date .
The Plan shall become effective (the “ Effective Date ”) upon approval by the stockholders of the Company.


1
11/21/2011 SL1 1072697v6 104212.00002


Exhibit 31.1

Certification of the Chief Executive Officer
Pursuant to Rules 13a-14(a) and 15d-14(a)
Under the Securities Exchange Act, as Amended

I, Theodore Wahl, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Healthcare Services Group, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s Board of Directors:

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date:
July 27, 2018
 
/s/ Theodore Wahl
 
 
 
Theodore Wahl
 
 
 
President & Chief Executive Officer
 
 
 
(Principal Executive Officer)






Exhibit 31.2

Certification of the Chief Financial Officer
Pursuant to Rules 13a-14(a) and 15d-14(a)
Under the Securities Exchange Act, as Amended

I, John C. Shea, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Healthcare Services Group, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s Board of Directors:

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date:
July 27, 2018
 
/s/ John C. Shea
 
 
 
John C. Shea
 
 
 
Chief Financial Officer
 
 
 
(Principal Financial and Accounting Officer)






Exhibit 32.1

Certification Pursuant to
18 U.S.C. Section 1350,
As Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report on Form 10-Q of Healthcare Services Group, Inc. (the "Company") for the quarter ended June 30, 2018 as filed with the Securities and Exchange commission on the date hereof (the "Form 10-Q"), Theodore Wahl, the Chief Executive Officer of the Company, and John C. Shea, the Chief Financial Officer of the Company, each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of their knowledge:

(1) The Form 10-Q fully complies with the requirements of Section 13(a) or 15(d), of the Securities Exchange Act of 1934, as amended; and

(2) That information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
 

/s/ Theodore Wahl
  
/s/ John C. Shea
Theodore Wahl
  
John C. Shea
President & Chief Executive Officer
  
Chief Financial Officer
(Principal Executive Officer)
 
(Principal Financial and Accounting Officer)
July 27, 2018
  
July 27, 2018